AUTHOR: Biomed Mom TITLE: Serotonin for ADHD DATE: 1/15/2009 07:37:00 AM ----- BODY:
Serotonin May Be Better Target For ADHD Treatment Researchers at the Howard Hughes Medical Institute (HHMI) at Duke University have discovered that Ritalin and other stimulants exert their paradoxical calming effects by boosting serotonin levels in the brain. Elevating serotonin appears to restore the delicate balance between the brain chemicals dopamine and serotonin and calms hyperactivity, says HHMI investigator Marc Caron at Duke University Medical Center. Caron is an author of the study published in the January 15 issue of the journal Science. Attention deficit hyperactivity disorder (ADHD) affects three to six per cent of school-aged children. Symptoms include restlessness, impulsiveness, and difficulty concentrating. Stimulants commonly used to treat ADHD are so effective that "researchers haven't really taken the time to investigate how they work," says Caron. Previous dogma, says Caron, held that the calming action of Ritalin works through the neurotransmitter dopamine. Specifically, researchers believed that Ritalin and other stimulants interact with the dopamine transporter protein (DAT), a housekeeper of sorts for nerve pathways. After a nerve impulse moves from one neuron to another, DAT removes residual dopamine from the synaptic cleft-the space between two neurons-and repackages it for future use. Caron's team suspected that dopamine wasn't the only key to understanding ADHD, so they turned to mice in which they had "knocked out" the gene that codes for DAT. Since there is no DAT to "mop up" dopamine from the synaptic cleft, the brains of the mice are flooded with dopamine. The excess dopamine causes restlessness and hyperactivity, behaviors that are strikingly similar to those exhibited by children with ADHD. When placed in a maze that normal mice negotiate in less than three minutes, the knockout mice became distracted-performing extraneous activities such as sniffing and rearing - and they failed to finish in less than five minutes. The knockout mice also seemed unable to suppress inappropriate impulses - another hallmark of ADHD. Surprisingly, the knockout mice were still calmed by Ritalin, Dexedrine and other stimulants even though they lacked the protein target on which Ritalin and Dexedrine were thought to act. "That caused us to look for other systems that these stimulants might affect," says Caron. To test whether the stimulants interact with dopamine through another mechanism, the researchers administered Ritalin to the normal and knockout mice and monitored their brain levels of dopamine. Ritalin boosted dopamine levels in the normal mice, but it did not alter dopamine levels in knockout mice. That result implied that "Ritalin could not be acting on dopamine," says Caron. They then studied whether the stimulants altered levels of the neurotransmitter serotonin. The scientists administered Prozac - a well-known inhibitor of serotonin reuptake - to the knockout mice. After ingesting Prozac, the knockout mice showed dramatic declines in hyperactivity. "This suggests that rather than acting directly on dopamine, the stimulants create a calming effect by increase serotonin levels," Caron says. "Our experiments imply that proper balance between dopamine and serotonin are key," says Raul Gainetdinov, a member of Caron's research team. "Hyperactivity may develop when the relationship between dopamine and serotonin is thrown off balance." The brain has 15 types of receptors that bind to serotonin, and Gainetdinov is now trying to determine which specific serotonin receptors mediate the effects of Ritalin. The hope, says Caron, "is that we can replace Ritalin with a very specific compound that targets a single subset of receptors." While Prozac calmed hyperactivity in the knockout mice, Gainetdinov says that "Prozac isn't the best, because it isn't very selective." Caron and Gainetdinov are optimistic that a new generation of compounds that interact more specifically with the serotonin system will prove to be safer and more effective for treatments for ADHD.

Labels: , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Serotonin's effects on multiple body systems DATE: 1/15/2009 07:15:00 AM ----- BODY:
One Dangerous Deficiency Links IBS, Migraines, and More Health News By VRP Staff When you think of serotonin deficiency, the first consequence that might spring to mind is depression. And if so, you’d be right. But there’s more to this neurotransmitter than meets the eye—a lot more. Migraines, irritable bowel syndrome, fibromyalgia, obesity, even asthma… believe it or not, all of these serious conditions can be traced back to depleted serotonin levels. And the effects on your body can be as damaging as they are diverse. Serotonin is one of your brain’s most crucial messengers. It’s released by your neurons to send signals to other neurons, after which it’s returned to its original parent neuron to be reused. But if your levels are low, serotonin’s time on your synapse is cut short. It’s recaptured before it can finish its job—at a very high cost to your health, mentally and physically. In addition to depression, low levels of serotonin–and its precursor tryptophan–have been linked to binge eating, carbohydrate cravings, and weight gain.1 Studies show that obese and overweight diabetic patients have levels that are well below normal–and in clinical trials, increased brain serotonin led to both reduced caloric intake and resulting weight loss.2–4 But it’s not just your waistline that benefits from this critical neurotransmitter. Studies have shown that increasing serotonin levels can fight insomnia by improving sleep continuity.5 Research also shows that increased serotonin relieves migraines as effectively as standard drug therapy and aids in relief of chronic tension headaches.6–7 This same ability has made it a unique target in the treatment of fibromyalgia, with serotonin deficiency implicated for lower pain thresholds and higher clinical measures of perceived pain in patients.8–10 In an even more surprising connection, serotonin has also been identified as a major player in gut motility.11–12 Special serotonin–releasing cells can be found throughout your digestive system, responsible for stimulating peristaltic motion and pushing waste through your digestive tract.13 Even the development and severity of asthma has been linked to depression, anxiety, and low–serotonin related disorders—revealing yet another function under this neurotransmitter’s powerful influence.14 Proper levels of serotonin are essential for your health—and one way to ensure higher levels of this neurotransmitter is by boosting your intake of tryptophan, an essential amino acid found in high–protein foods that is responsible for serotonin synthesis in your brain. Research has shown that supplementing with tryptophan (and its metabolite 5–hydroxytryptophan, or 5–HTP) can replenish serotonin naturally and effectively—easing depression, anxiety, migraines, insomnia, and fibromyalgia symptoms in several clinical studies.15–17 References: 1. Gendall KA, Joyce PR. Meal–induced changes in tryptophan:LNAA ratio: effects on craving and binge eating. Eat Behav. 2000 Sep;1(1):53–62. 2. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty–four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003 May;77(5):1112–1118. 3. Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5–hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76(2):109–117. 4. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5–hydroxytryptophan. Am J Clin Nutr 1992 Nov;56(5):863–867. 5. Riemann D, Vorderholzer U. Treatment of depression and sleep disorders. Significance of serotonin and L–tryptophan in pathophysiology and therapy. Fortschr Med. 1998 Nov;116(32):40–42. 6. Titus F, Dávalos A, Alom J, Codina A. 5–Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol. 1986;25(5):327–329. 7. Ribeiro CA. L–5–Hydroxytryptophan in the prophylaxis of chronic tension–type headache: a double–blind, randomized, placebo–controlled study. For the Portuguese Head Society. Headache. 2000 Jun;40(6):451–456. 8. Birdsall TC. 5–Hydroxytryptophan: a clinically–effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271–280. 9. Hrycaj P, Stratz T, Muller W. Platelet 3Himipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1993;20:1986–1988. [letter] 10. Russell IJ, Michalek JE, Vipraio GA, et al. Platelet 3H–imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104–109. 11. Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008 Feb;4(1):41–48. 12. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Minneap). 1999 Jul 15;34(7):31–32,35–38,41–42. 13. Grider JR. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5–HT4 agonist tegaserod. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G319–G327. 14. Goodwin RD, Sourander A, Duarte CS, et al. Do mental health problems in childhood predict chronic physical conditions among males in early adulthood? Evidence from a community–based prospective study. Psychol Med. 2008 May 28:1–11. 15. Poldinger W, Calanchini B, Schwarz W. A functional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5–hydroxytryptophan and fluvoxamine. Psychopathology. 1991;24:53–81. 16. Kahn RS, Westenberg HG. L–5–hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord. 1985 Mar–Apr;8(2):197–200. 17. Puttini PS, Caruso I. Primary fibromyalgia and 5–hydroxy–L–tryptophan: a 90 day open study. J Int Med Res. 1992;20:182–189.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: PTSD and neurobiology DATE: 4/29/2008 05:05:00 PM ----- BODY:
The Body Keeps The Score:
Memory & the Evolving Psychobiology of Post Traumatic Stress
by Bessel van der Kolk


Bessel A. van der Kolk, MD.
Harvard Medical School
HRI Trauma Center
227 Babcock Street
Boston, MA 02146

This is a version of an article first published in the Harvard Review of Psychiatry, 1994, 1(5), 253-265. Note that this online version may have minor differences from the published version.
The author wishes to thank Rita Fisler, Ed.M. for her editorial assistance.
Background

For more than a century, ever since people's responses to overwhelming experiences were first systematically explored, it has been noted that the psychological effects of trauma are expressed as changes in the biological stress response. In 1889, Pierre Janet (1), postulated that intense emotional reactions make events traumatic by interfering with the integration of the experience into existing memory schemes. Intense emotions, Janet thought, cause memories of particular events to be dissociated from consciousness, and to be stored, instead, as visceral sensations (anxiety and panic), or as visual images (nightmares and flashbacks). Janet also observed that traumatized patients seemed to react to reminders of the trauma with emergency responses that had been relevant to the original threat, but that had no bearing on current experience. He noted that victims had trouble learning from experience: unable to put the trauma behind them, their energies were absorbed by keeping their emotions under control at the expense of paying attention to current exigencies. They became fixated upon the past, in some cases by being obsessed with the trauma, but more often by behaving and feeling like they were traumatized over and over again without being able to locate the origins of these feelings (2,3).

Freud also considered the tendency to stay fixated on the trauma to be biologically based: "After severe shock.. the dream life continually takes the patient back to the situation of his disaster from which he awakens with renewed terror.. the patient has undergone a physical fixation to the trauma"(4). Pavlov's investigations continued the tradition of explaining the effects of trauma as the result of lasting physiological alterations. He, and others employing his paradigm, coined the term "defensive reaction" for a cluster of innate reflexive responses to environmental threat (5). Many studies have shown how the response to potent environmental stimuli (unconditional stimuli-US) becomes a conditioned reaction. After repeated aversive stimulation, intrinsically non-threatening cues associated with the trauma (conditional stimuli-CS) become capable of eliciting the defensive reaction by themselves (conditional response-CR). A rape victim may respond to conditioned stimuli, such as the approach by an unknown man, as if she were about to be raped again, and experience panic. Pavlov also pointed out that individual differences in temperament accounted for the diversity of long term adaptations to trauma.

Abraham Kardiner(6), who first systematically defined posttraumatic stress for American audiences, noted that sufferers from "traumatic neuroses" develop an enduring vigilance for and sensitivity to environmental threat, and stated that "the nucleus of the neurosis is a physioneurosis. This is present on the battlefield and during the entire process of organization; it outlives every intermediary accommodative device, and persists in the chronic forms. The traumatic syndrome is ever present and unchanged". In "Men under Stress", Grinker and Spiegel (7) catalogue the physical symptoms of soldiers in acute posttraumatic states: flexor changes in posture, hyperkinesis, "violently propulsive gait", tremor at rest, masklike facies, cogwheel rigidity, gastric distress, urinary incontinence, mutism, and a violent startle reflex. They noted the similarity between many of these symptoms and those of diseases of the extrapyramidal motor system. Today we can understand them as the result of stimulation of biological systems, particularly of ascending amine projections. Contemporary research on the biology of PTSD, generally uninformed by this earlier research, confirms that there are persistent and profound alterations in stress hormones secretion and memory processing in people with PTSD.
The Symptomatology of PTSD

Starting with Kardiner(6), and closely followed by Lindemann (8), a vast literature on combat trauma, crimes, rape, kidnapping, natural disasters, accidents and imprisonment have shown that the trauma response is bimodal: hypermnesia, hyper-reactivity to stimuli and traumatic reexperiencing coexist with psychic numbing, avoidance, amnesia and anhedonia (9,10,11,12). These responses to extreme experiences are so consistent across traumatic stimuli that this biphasic reaction appears to be the normative response to any overwhelming and uncontrollable experience. In many people who have undergone severe stress, the post-traumatic response fades over time, while it persists in others. Much work remains to be done to spell out issues of resilience and vulnerability, but magnitude of exposure, prior trauma, and social support appear to be the three most significant predictors for developing chronic PTSD (13,14).

In an apparent attempt to compensate for chronic hyperarousal, traumatized people seem to shut down: on a behavioral level, by avoiding stimuli reminiscent of the trauma; on a psychobiological level, by emotional numbing, which extends to both trauma-related, and everyday experience (15). Thus, people with chronic PTSD tend to suffer from numbing of responsiveness to the environment, punctuated by intermittent hyperarousal in response to conditional traumatic stimuli. However, as Pitman has pointed out (16), in PTSD, the stimuli that precipitate emergency responses may not be conditional enough: many triggers not directly related to the traumatic experience may precipitate extreme reactions. Thus, people with PTSD suffer both from generalized hyperarousal and from physiological emergency reactions to specific reminders(9,10) The loss of affective modulation that is so central in PTSD mayhelp explain the observation that traumatized people lose the capacity to utilize affect states as signals (18). Instead of using feelings as cues to attend to incoming information, in people with PTSD arousal is likely to precipitate flight or fight reactions (19). Thus, they are prone to go immediately from stimulus to response without making the necessary psychological assessment of the meaning of what is going on. This makes them prone to freeze, or, alternatively, to overreact and intimidate others in response to minor provocations (12,20).
Psychophysiology

Abnormal psychophysiological responses in PTSD have been demonstrated on two different levels: 1) in response to specific reminders of the trauma and 2) in response to intense, but neutral stimuli, such as acoustic startle. The first paradigm implies heightened physiological arousal to sounds, images, and thoughts related to specific traumatic incidents. A large number of studies have confirmed that traumatized individuals respond to such stimuli with significant conditioned autonomic reactions, such as heart rate, skin conductance and blood pressure (20,21,22,23, 24,25). The highly elevated physiological responses that accompany the recall of traumatic experiences that happened years, and sometimes decades before, illustrate the intensity and timelessness with which traumatic memories continue to affect current experience (3,16). This phenomenon has generally been understood in the light of Peter Lang's work (26) which shows that emotionally laden imagery correlates with measurable autonomic responses. Lang has proposed that emotional memories are stored as "associative networks", that are activated when a person is confronted with situations that stimulate a sufficient number of elements that make up these networks. One significant measure of treatment outcome that has become widely accepted in recent years is a decrease in physiological arousal in response to imagery related to the trauma (27). However, Shalev et al (28) have shown that desensitization to specific trauma-related mental images does not necessarily generalize to recollections of other traumatic events, as well.

Kolb (29) was the first to propose that excessive stimulation of the CNS at the time of the trauma may result in permanent neuronal changes that have a negative effect on learning, habituation, and stimulus discrimination. These neuronal changes would not depend on actual exposure to reminders of the trauma for expression. The abnormal startle response characteristic of PTSD (10) exemplifies such neuronal changes.

Despite the fact that an abnormal acoustic startle response (ASR) has been seen as a cardinal feature of the trauma response for over half a century, systematic explorations of the ASR in PTSD have just begun. The ASR consists of a characteristic sequence of muscular and autonomic responses elicited by sudden and intense stimuli (30,31). The neuronal pathways involved consist of only a small number of mediating synapses between the receptor and effector and a large projection to brain areas responsible for CNS activation and stimulus evaluation (31). The ASR is mediated by excitatory amino acids such as glutamate and aspartate and is modulated by a variety of neurotransmitters and second messengers at both the spinal and supraspinal level (32). Habituation of the ASR in normals occurs after 3 to 5 presentations (30).

Several studies have demonstrated abnormalities in habituation to the ASR in PTSD (33,34,35,36). Shalev et al (33) found a failure to habituate both to CNS and ANS-mediated responses to ASR in 93% of the PTSD group, compared with 22% of the control subjects. Interestingly, people who previously met criteria for PTSD, but no longer do so now, continue to show failure of habituation of the ASR (van der Kolk et al, unpublished data; Pitman et al, unpublished data), which raises the question whether abnormal habituation to acoustic startle is a marker of, or a vulnerability factor for developing PTSD.

The failure to habituate to acoustic startle suggests that traumatized people have difficulty evaluating sensory stimuli, and mobilizing appropriate levels of physiological arousal(30). Thus, the inability of people with PTSD to properly integrate memories of the trauma and, instead, to get mired in a continuous reliving of the past, is mirrored physiologically in the misinterpretation of innocuous stimuli, such as the ASR, as potential threats.
The Hormonal Stress Response & the Psychobiology of PTSD

Post Traumatic Stress Disorder develops following exposure to events that are intensely distressing. Intense stress is accompanied by the release of endogenous, stress-responsive neurohormones, such as cortisol, epinephrine and norepinephrine (NE), vasopressin, oxytocin and endogenous opioids. These stress hormones help the organism mobilize the required energy to deal with the stress, ranging from increased glucose release to enhanced immune function. In a well-functioning organism, stress produces rapid and pronounced hormonal responses. However, chronic and persistent stress inhibits the effectiveness of the stress response and induces desensitization (37).

Much still remains to be learned about the specific roles of the different neurohormones in the stress response. NE is secreted by the Locus Coeruleus(LC) and distributed through much of the CNS, particularly the neocortex and the limbic system, where it plays a role in memory consolidation and helps initiate fight/ flight behaviors. Adrenocorticotropin (ACTH) is released from the anterior pituitary, and activates a cascade of reactions, eventuating in release of glucocorticoids from the adrenals. The precise interrelation between Hypothalamic-Pituitary-Adrenal (HPA) Axis hormones and the catecholamines in the stress response is not entirely clear, but it is known that stressors that activate NE neurons also increase CRF concentrations in the LC (38), while intracerebral ventricular infusion of CRF increases NE in the forebrain (39). Glucocorticoids and catecholamines may modulate each other's effects: in acute stress, cortisol helps regulate stress hormone release via a negative feedback loop to the hippocampus, hypothalamus and pituitary (40) and there is evidence that corticosteroids normalize catecholamine-induced arousal in limbic midbrain structures in response to stress (41). Thus, the simultaneous activation of corticosteroids and catecholamines could stimulate active coping behaviors, while increased arousal in the presence of low glucocorticoid levels may promote undifferentiated fight or flight reactions (42).

While acute stress activates the HPA axis and increases glucocorticoid levels, organisms adapt to chronic stress by activating a negative feedback loop that results in 1) decreased resting glucocorticoid levels in chronically stressed organisms, (43), 2) decreased glucocorticoid secretion in response to subsequent stress (42), and 3) increased concentration of glucocorticoid receptors in the hippocampus (44). Yehuda has suggested that increased concentration of glucocorticoid receptors could facilitate a stronger glucocorticoid negative feedback, resulting in a more sensitive HPA axis and a faster recovery from acute stress (45).

Chronic exposure to stress affects both acute and chronic adaptation: it permanently alters how an organism deals with its environment on a day-to-day basis, and it interferes with how it copes with subsequent acute stress (45).
Neuroendocrine Abnormalities in PTSD

Since there is an extensive animal literature on the effects of inescapable stress on the biological stress response of other species, such as monkeys and rats, much of the biological research on people with PTSD has focussed on testing the applicability of those research findings to people with PTSD (46,47). People with PTSD, like chronically and inescapbly shocked animals, seem to suffer from a persistent activation of the biological stress response upon exposure to stimuli reminiscent of the trauma.

1) Catecholamines. Neuroendocrine studies of Vietnam veterans with PTSD have found good evidence for chronically increased sympathetic nervous system activity in PTSD. One study (48) found elevated 24h excretions of urinary NE and epinephrine in PTSD combat veterans compared with patients with other psychiatric diagnoses. While Pitman & Orr (49) did not replicate these findings in 20 veterans and 15 combat controls, the mean urinary NE excretion values in their combat controls (58.0 ug/day) were substantially higher than those previously reported in normal populations. The expected compensatory downregulation of adrenergic receptors in response to increased levels of norepinephrine was confirmed by a study that found decreased platelet alpha-2 adrenergic receptors in combat veterans with PTSD, compared with normal controls (50). Another study also found an abnormally low alpha-2 adrenergic receptor-mediated adenylate cyclase signal transduction (51). In a recent study Southwick et al (52) used yohimbine injections (0.4 mg/kg), which activate noradrenergic neurons by blocking the alpha-2 auto- receptor, to study noradrenergic neuronal dysregulation in Vietnam veterans with PTSD. Yohimbine precipitated panic attacks in 70% of subjects and flashbacks in 40%. Subjects responded with larger increases in plasma MHPG than controls. Yohimbine precipitated significant increases in all PTSD symptoms.

2) Corticosteroids. Two studies have shown that veterans with PTSD have low urinary cortisol excretion, even when they have comorbid major depressive disorder (42,53). One study failed to replicate this finding (49). In a series of studies, Yehuda et al (42,54) found increased numbers of lymphocyte glucocorticoid receptors in Vietnam veterans with PTSD. Interestingly, the number of glucocorticoid receptors was proportional to the severity of PTSD symptoms. Yehuda (54) also has reported the results of an unpublished study by Heidi Resnick, in which acute cortisol response to trauma was studied from blood samples from 20 acute rape victims. Three months later, a prior trauma history was taken, and the subjects were evaluated for the presence of PTSD. Victims with a prior history of sexual abuse were significantly more likely to have developed PTSD three months following the rape than rape victims who did not develop PTSD. Cortisol levels shortly after the rape were correlated with histories of prior assaults: the mean initial cortisol level of individuals with a prior assault history was 15 ug/dl compared to 30 ug/dl in individuals without. These findings can be interpreted to mean either that prior exposure to traumatic events result in a blunted cortisol response to subsequent trauma, or in a quicker return of cortisol to baseline following stress. The fact that Yehuda et al (45) also found subjects with PTSD to be hyperresponsive to low doses of dexamethasone argues for an enhanced sensitivity of the HPA feedback in traumatized patients.

3) Serotonin. While the role of serotonin in PTSD has not been systematically investigated, both the fact that inescapably shocked animals develop decreased CNS serotonin levels (55), and that serotonin re-uptake blockers are effective pharmacological agents in the treatment of PTSD, justify a brief consideration of the potential role of this neurotransmitter in PTSD. Decreased serotonin in humans has repeatedly been correlated with impulsivity and aggression (56,57,58). The literature tends to readily assume that these relationships are based on genetic traits. However, studies of impulsive, aggressive and suicidal patients seem to find at least as robust an association between those behaviors and histories of childhood trauma (e.g. 59,60,61). It is likely that both temperament and experience affect relative CNS serotonin levels (12).

Low serotonin in animals is also related to an inability to modulate arousal, as exemplified by an exaggerated startle (62,63), and increased arousal in response to novel stimuli, handling, or pain (63). The behavioral effects of serotonin depletion on animals is characterized by hyperirritability, hyperexitability, and hypersensitivity, and an "...exaggerated emotional arousal and/or aggressive display, to relatively mild stimuli" (63). These behaviors bear a striking resemblance to the phenomenology of PTSD in humans. Furthermore, serotonin re-uptake inhibitors have been found to be the most effective pharmacological treatment of both obsessive thinking in people with OCD (64), and of involuntary preoccupation with traumatic memories in people with PTSD (65,66). It is likely that serotonin plays a role in the capacity to monitor the environment flexibly and to respond with behaviors that are situation-appropriate, rather than reacting to internal stimuli that are irrelevant to current demands.

4). Endogenous opioids. Stress induced analgesia (SIA) has been described in experimental animals following a variety of inescapable stressors such as electric shock, fighting, starvation and cold water swim (67). In severely stressed animals, opiate withdrawal symptoms can be produced both by termination of the stressful stimulus or by naloxone injections. Stimulated by the findings that fear activates the secretion of endogenous opioid peptides, and that SIA can become conditioned to subsequent stressors and to previously neutral events associated with the noxious stimulus, we tested the hypothesis that in people with PTSD, re-exposure to a stimulus resembling the original trauma will cause an endogenous opioid response that can be indirectly measured as naloxone reversible analgesia (68,69). We found that two decades after the original trauma, people with PTSD developed opioid-mediated analgesia in response to a stimulus resembling the traumatic stressor, which we correlated with a secretion of endogenous opioids equivalent to 8 mg of morphine. Self-reports of emotional responses suggested that endogenous opioids were responsible for a relative blunting of the emotional response to the traumatic stimulus.
Endogenous Opiates & Stress Induced Analgesia: Possible Implications for Affective Function

When young animals are isolated, and older ones attacked, they respond initially with aggression (hyperarousal- fight- protest), and, if that does not produce the required results, with withdrawal (numbing-flight-despair). Fear-induced attack or protest patterns in the young serve to attract protection, and in mature animals to prevent or counteract the predator's activity. During external attacks pain-inhibition is a useful defensive capacity, because attention to pain would interfere with effective defense: grooming or licking wounds may attract opponents and stimulate further attack (70). Thus defensive and pain-motivated behaviors are mutually inhibitory. Stress-induced analgesia protects organisms against feeling pain while engaged in defensive activities. As early as 1946, Beecher (71), after observing that 75% of severely wounded soldiers on the Italian front did not request morphine, speculated that "strong emotions can block pain". Today, we can reasonably assume that this is due to the release of endogenous opioids(68,69).

Endogenous opioids, which inhibit pain and reduce panic, are secreted after prolonged exposure to severe stress. Siegfried et al (70) have observed that memory is impaired in animals when they can no longer actively influence the outcome of a threatening situation. They showed that both the freeze response and panic interfere with effective memory processing: excessive endogenous opioids and NE both interfere with the storage of experience in explicit memory. Freeze/numbing responses may serve the function of allowing organisms to not "consciously experience" or not to remember situations of overwhelming stress (and which thus will also keep them from learning from experience). We have proposed that the dissociative reactions in people in response to trauma may be analogous to this complex of behaviors that occur in animals after prolonged exposure to severe uncontrollable stress (68).
Developmental Level Affects the Psychobiological Effects of Trauma

While most studies on PTSD have been done on adults, particularly on war veterans, in recent years a small prospective literature is emerging that documents the differential effects of trauma at various age levels. Anxiety disorders, chronic hyperarousal, and behavioral disturbances have been regularly described in traumatized children (e.g.72,73,74). In addition to the reactions to discrete, one time, traumatic incidents documented in these studies, intrafamilial abuse is increasingly recognized to produce complex post-traumatic syndromes (75), which involve chronic affect dysregulation, destructive behavior against self and others, learning disablities, dissociative problems, somatization, and distortions in concepts about self and others (76,77). The Field Trials for DSM IV showed that these this conglomeration of symptoms tended to occur together and that the severity of this syndrome was proportional to the age of onset of the trauma and its duration (78).

While current research on traumatized children is outside the scope of this review, it is important to recognize that a range of neurobiological abnormalities are beginning to be identified in this population. Frank Putnam's prospective, but as yet unpublished, studies (personal communications, 1991,1992,1993) are showing major neuroendocrine disturbances in sexually abused girls compared with normals. Research on the psychobiology of childhood trauma can be profitably informed by the vast literature on the psychobiological effects of trauma and deprivation in non-human primates (12,79).
Trauma & Memory: The Flexibility of Memory & the Engraving of Trauma

One hundred years ago, Pierre Janet (1) suggested that the most fundamental of mental activities is the storage and categorization of incoming sensations into memory, and the retrieval of those memories under appropriate circumstances. He, like contemporary memory researchers, understood that what is now called semantic, or declarative, memory is an active and constructive process and that remembering depends on existing mental schemata (3,80): once an event or a particular bit of information is integrated into existing mental schemes, it will no longer be accessible as a separate, immutable entity, but be distorted both by prior experience, and by the emotional state at the time of recall(3). PTSD, by definition, is accompanied by memory disturbances, consisting of both hypermnesias and amnesias (9,10). Research into the nature of traumatic memories (3) indicates that trauma interferes with delarative memory, i.e. conscious recall of experience, but does not inhibit implicit, or non-declarative memory, the memory system that controls conditioned emotional responses, skills and habits, and sensorimotor sensations related to experience. There now is enough information available about the biology of memory storage and retrieval to start building coherent hypotheses regarding the underlying psychobiological processes involved in these memory disturbances (3,16,17,25).

In the beginning of this century Janet already noted that: "certain happenings ... leave indelible and distressing memories-- memories to which the sufferer continually returns, and by which he is tormented by day and by night" (81). Clinicians and researchers dealing with traumatized patients have repeatedly made the observation that the sensory experiences and visual images related to the trauma seem not to fade over time, and appear to be less subject to distortion than ordinary experiences (1,49,82). When people are traumatized, they are said to experience "speechless terror": the emotional impact of the event may interfere with the capacity to capture the experience in words or symbols. Piaget (83) thought that under such circumstances, failure of semantic memory leads to the organization of memory on a somatosensory or iconic level (such as somatic sensations, behavioral enactments, nightmares and flashbacks). He pointed out: "It is precisely because there is no immediate accommodation that there is complete dissociation of the inner activity from the external world. As the external world is solely represented by images, it is assimilated without resistance (i.e. unattached to other memories) to the unconscious ego".
Traumatic memories are state dependent.

Research has shown that, under ordinary conditions, many traumatized people, including rape victims (84), battered women (85) and abused children (86) have a fairly good psychosocial adjustment. However, they do not respond to stress the way other people do. Under pressure, they may feel, or act as if they were traumatized all over again. Thus, high states of arousal seem to selectively promote retrieval of traumatic memories, sensory information, or behaviors associated with prior traumatic experiences (9,10). The tendency of traumatized organisms to revert to irrelevant emergency behaviors in response to minor stress has been well documented in animals, as well. Studies at the Wisconsin primate laboratory have shown that rhesus monkeys with histories of severe early maternal deprivation display marked withdrawal or aggression in response to emotional or physical stimuli (such as exposure to loud noises, or the administration of amphetamines), even after a long period of good social adjustment (87). In experiments with mice, Mitchell and his colleagues (88) found that the relative degree of arousal interacts with prior exposure to high stress to determine how an animal will react to novel stimuli. In a state of low arousal, animals tend to be curious and seek novelty. During high arousal, they are frightened, avoid novelty, and perseverate in familiar behavior, regardless of the outcome. Under ordinary circumstances, an animal will choose the most pleasant of two alternatives. When hyperaroused, it will seek whatever is familiar, regardless of the intrinsic rewards. Thus, animals who have been locked in a box in which they were exposed to electric shocks and then released return to those boxes when they are subsequently stressed. Mitchell concluded that this perseveration is nonassociative, i.e. uncoupled from the usual reward systems.

In people, analogous phenomena have been documented: memories (somatic or symbolic) related to the trauma are elicited by heightened arousal (89). Information acquired in an aroused, or otherwise altered state of mind is retrieved more readily when people are brought back to that particular state of mind (90,91). State dependent memory retrieval may also be involved in dissociative phenomena in which traumatized persons may be wholly or partially amnestic for memories or behaviors enacted while in altered states of mind (2,3,92).

Contemporary biological researchers have shown that medications that stimulate autonomic arousal may precipitate visual images and affect states associated with prior traumatic experiences in people with PTSD, but not in controls. In patients with PTSD the injection of drugs such as lactate (93) and yohimbine (52) tends to precipitate panic attacks, flashbacks (exact reliving experiences) of earlier trauma, or both. In our own laboratory, approximately 20% of PTSD subjects responded with a flashback of a traumatic experience when they were presented with acoustic startle stimuli.
Trauma, neurohormones and memory consolidation.

When people are under severe stress, they secrete endogenous stress hormones that affect the strength of memory consolidation. Based on animal models it has been widely assumed (3,46,94) that massive secretion of neurohormones at the time of the trauma plays a role in the long term potentiation (LTP) (and thus, the over- consolidation) of traumatic memories. Mammals seem equipped with memory storage mechanisms that ordinarily modulate the strength of memory consolidation according to the strength of the accompanying hormonal stimulation (95,96). This capacity helps the organism evaluate the importance of subsequent sensory input according to the relative strength of associated memory traces. This phenomenon appears to be largely mediated by NE input to the amygdala (97,98, figure 2). In traumatized organisms, the capacity to access relevant memories appears to have gone awry: they become overconditioned to access memory traces of the trauma and to "remember" the trauma whenever aroused. While norepinephrine (NE) seems to be the principal hormone involved in producing LTP, other neurohormones secreted under particular stressful circumstances, such as endorphins and oxytocin, actually inhibit memory consolidation (99).

The role of NE in memory consolidation has been shown to have an inverted U-shaped function (95,96): both very low and very high levels of CNS NE activity interfere with memory storage. Excessive NE release at the time of the trauma, as well as the release of other neurohormones, such as endogenous opioids, oxytocin and vasopressin, are likely to play a role in creating the hypermnesias and the amnesias that are a quintessential part of PTSD (9,10). It is of interest that childbirth, which can be extraordinarily stressful, almost never seems to result in post traumatic problems (100). Oxytocin may play a protective role that prevents the overconsolidation of memories surrounding childbirth.

Physiological arousal in general can trigger trauma-related memories, while, conversely, trauma-related memories precipitate generalized physiological arousal. It is likely that the frequent re-living of a traumatic event in flashbacks or nightmares cause a re-release of stress hormones which further kindle the strength of the memory trace (46). Such a positive feedback loop could cause subclinical PTSD to escalate into clinical PTSD (16), in which the strength of the memories appear so deeply engraved that Pitman and Orr (17) have called it "the Black Hole" in the mental life of the PTSD patient, that attracts all associations to it, and saps current life of its significance.
Memory, Trauma & the Limbic System

The limbic system is thought to be the part of the CNS that maintains and guides the emotions and behavior necessary for self-preservation and survival of the species (101), and that is critically involved in the storage and retrieval of memory. During both waking and sleeping states signals from the sensory organs continuously travel to the thalamus whence they are distributed to the cortex (setting up a "stream of thought"), to the basal ganglia (setting up a "stream of movement") and to the limbic system where they set up a "stream of emotions"(102), that determine the emotional significance of the sensory input. It appears that most processing of sensory input occurs outside of conscious awareness, and only novel, significant or threatening information is selectively passed on to the neocortex for further attention. Since people with PTSD appear to over-interpret sensory input as a recurrence of past trauma and since recent studies have suggested limbic system abnormalities in brain imaging studies of traumatized patients (103,104), a review of the psychobiology of trauma would be incomplete without considering the role of the limbic system in PTSD (also see 105). Two particular areas of the limbic system have been implicated in the processing of emotionally charged memories: the amygdala and the hippocampus (Table 2).

The amygdala. Of all areas in the CNS, the amygdala is most clearly implicated in the evaluation of the emotional meaning of incoming stimuli (106). Several investigators have proposed that the amygdala assigns free-floating feelings of significance to sensory input, which the neocortex then further elaborates and imbues with personal meaning (101,106,107,108). Moreover, it is thought to integrate internal representations of the external world in the form of memory images with emotional experiences associated with those memories (80). After assigning meaning to sensory information, the amygdala guides emotional behavior by projections to the hypothalamus, hippocampus and basal forebrain (106,107,109).

The septo-hippocampal system, which anatomically is adjacent to the amygdala, is thought to record in memory the spatial and temporal dimensions of experience and to play an important role in the categorization and storage of incoming stimuli in memory. Proper functioning of the hippocampus is necessary for explicit or declarative memory (109). The hippocampus is thought to be involved in the evaluation of spatially and temporally unrelated events, comparing them with previously stored information and determining whether and how they are associated with each other, with reward, punishment, novelty or non-reward (107,110). The hippocampus is also implicated in playing a role in the inhibition of exploratory behavior and in obsessional thinking, while hippocampal damage is associated with hyper-responsiveness to environmental stimuli (111,112).

The slow maturation of the hippocampus, which is not fully myelinated till after the third or fourth year of life, is seen as the cause of infantile amnesia (113,114). In contrast, it is thought that the memory system that subserves the affective quality of experience (roughly speaking procedural, or "taxon" memory) matures earlier and is less subject to disruption by stress (112).

As the CNS matures, memory storage shifts from primarily sensorimotor (motoric action) and perceptual representations (iconic), to symbolic and linguistic modes of organization of mental experience (83). With maturation, there is an increasing ability to categorize experience, and link it with existing mental schemes. However, even as the organism matures, this capacity, and with it, the hippocampal localization system, remains vulnerable to disruption (45,107,110,115,116). A variety of external and internal stimuli, such as stress induced corticosterone production (117), decreases hippocampal activity. However, even when stress interferes with hippocampally mediated memory storage and categorization, it is likely that some mental representation of the experience is laid down by means of a system that records affective experience, but that has no capacity for symbolic processing and placement in space and time (figure 2).

Decreased hippocampal functioning causes behavioral disinhibition, possibly by stimulating incoming stimuli to be interpreted in the direction of "emergency" (fight/flight) responses. The neurotransmitter serotonin plays a crucial role in the capacity of the septo-hippocampal system to activate inhibitory pathways that prevent the initiation of emergency responses until it is clear that they will be of use (110). This observation made us very interested in a possible role for serotonergic agents in the treatment of PTSD.
"Emotional memories are forever"

In animals, high level stimulation of the amygdala interferes with hippocampal functioning (107, 109). This implies that intense affect may inhibit proper evaluation and categorization of experience. In mature animals one-time intense stimulation of the amygdala will produce lasting changes in neuronal excitability and enduring behavioral changes in the direction of either fight or flight (118). In kindling experiments with animals, Adamec et al (119) have shown that, following growth in amplitude of amygdala and hippocampal seizure activity, permanent changes in limbic physiology cause a lasting changes in defensiveness and in predatory aggression. Pre-existing "personality" played a significant role in the behavioral effects of amygdala stimulation in cats: animals that are temperamentally insensitive to threat and prone to attack tend become more aggressive, while in highly defensive animals different pathways were activated, increasing behavioral inhibition (119).

In a series of experiments, LeDoux has utilized repeated electrical stimulation of the amygdala to produce conditioned fear responses. He found that cortical lesions prevent their extinction. This led him to conclude that, once formed, the subcortical traces of the conditioned fear response are indelible, and that "emotional memory may be forever" (118). In 1987, Lawrence Kolb (29) postulated that patients with PTSD suffer from impaired cortical control over subcortical areas responsible for learning, habituation, and stimulus discrimination. The concept of indelible subcortical emotional responses, held in check to varying degrees by cortical and septo-hippocampal activity, has led to the speculation that delayed onset PTSD may be the expression of subcortically mediated emotional responses that escape cortical, and possibly hippocampal, inhibitory control (3,16,94,120,121).

Decreased inhibitory control may occur under a variety of circumstances: under the influence of drugs and alcohol, during sleep (as nightmares), with aging, and after exposure to strong reminders of the traumatic past. It is conceivable that traumatic memories then could emerge, not in the distorted fashion of ordinary recall, but as affect states, somatic sensations or as visual images (nightmares [81] or flashbacks [52]) that are timeless and unmodified by further experience.
Psychopharmacological Treatment

The goal of treatment of PTSD is to help people live in the present, without feeling or behaving according to irrelevant demands belonging to the past. Psychologically, this means that traumatic experiences need to be located in time and place and distinguished from current reality. However, hyperarousal, intrusive reliving, numbing and dissociation get in the way of separating current reality from past trauma. Hence, medications that affect these PTSD symptoms are often essential for patients to begin to achieve a sense of safety and perspective from which to approach their tasks. While numerous articles have been written about the drug treatment of PTSD, to date, only 134 people with PTSD have been enrolledin published double blind studies. Most of these have been Vietnamcombat veterans. Unfortunately, up until recently, only medications which seem to be of limited therapeutic usefulness have beenthesubject of adequate scientific scrutiny. While the only published double blind studies of medications in the treatment of PTSDhave been tricyclic antidepressants and MAO Inhibitors (122,123,124), it is sometimes assumed that they therefore also are themosteffective. Three double-blind trials of tricyclic antidepressants have been published (122,124,125), two of which demonstrated modest improvement in PTSD symptoms. While positive resultshave been claimed for numerous other medications in case reportsand open studies, at the present time there are no data aboutwhich patient and which PTSD symptom will predictably respond toanyof them. Success has been claimed for just about every class ofpsychoactive medication, including benzodiazepines (127), tricyclic antidepressants (122,125), monamine oxidase inhibitors (122,129) lithium carbonate (127), beta adrenergic blockers and clonidine (130), carbamezapine (131) and antipsychotic agents. The accumulated clinical experience seems to indicate that understanding thebasic neurobiology of arousal and appraisal is the most useful guideinselecting medications for people with PTSD (124,125). Autonomic arousal can be reduced at different levels in the CNS: throughinhibition of locus coeruleus noradrenergic activity with clonidine and the beta adrenergic blockers (130,132), or by increasing the inhibitory effect of the gaba-ergic system with gaba- ergicagonists (the benzodiazepines). During the past two years a numberof case reports and open clinical trials of fluoxetine were followedby our double blind study of 64 PTSD subjects with fluoxetine (65). Unlike the tricyclic antidepressants, which were effective on either the intrusive (imipramine) or numbing (amitryptiline) symptoms of PTSD, fluoxetine proved to be effective forthewhole spectrum of PTSD symptoms. It also acted more rapidly thanthetricyclics. The fact that fluoxetine has proven to be such aneffective treatment for PTSD supports a larger role of the serotonergic system in PTSD (66). Rorschach tests adminstered by blindscorers revealed that subjects on fluoxetine became able to takedistance from the emotional impact of incoming stimuli and to becomeable to utilize cognition to harness the emotional responses tounstructured visual stimuli (van der Kolk et al, unpublished).

While the subjects improved clinically, their startle habituation got worse (van der Kolk et al, unpublished). The 5-HT1a agonist buspirone shows some promise in facilitating habituation (133) and thus may play a useful adjunctive role in the pharmaco- therapy of PTSD. Even newer research has suggested abnormalities of the N-methyl-D-aspartate (NMDA) receptor and of glutamate in PTSD (134), opening up potential new avenues for the psychopharmacological treatment of PTSD.

Labels: , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Nutrient defieciency and aggression DATE: 11/19/2007 05:35:00 PM ----- BODY:
Melvyn R. Werbach, M.D. Journal Of Orthomolecular Medicine Vol. 7, No. 1, 1995 Introduction The aggressive behavioral syndrome is marked by restlessness, irritability, impulsivity and a proneness to violence. Diagnostically, it overlaps the DSM III-R diagnoses of Attention-deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant Disorder and Antisocial Personality Disorder. When the syndrome is attributed to organic factors, it would frequently be classified as an Organic Personality Syndrome.1 Constitutional factors, including genetics and the effects of disease and physical trauma, are known to play a major role in determining proneness to overaggressive behaviors. The importance of psychological factors is also well known. By contrast, the contribution of nutritional factors to such behaviors is often unrecognized, and therefore not properly addressed. Nutritional factors are neglected for a number of reasons. Much of the literature on nutritional treatments has yet to evolve beyond the early stages of scientific investigation. Physicians learn so little about nutritional medicine during their training that they feel too uninformed to include it in their practices. Sub-optimal nutrition is generally believed to be rare in industrialized societies - even though up to 50% of the population may fail to ingest the Recommended Dietary Allowance for one or more vitamins or minerals.2 In regard to behavioral syndromes, nutritional factors are neglected, in part, because marginal nutritional deficiencies are not believed to affect behavior despite growing evidence to suggest that that belief may be false. (For example, subtle neuropsychological impairment has been documented by EEG recordings of older subjects in association with any of a number of marginal nutritional deficiencies. 3 Literature Review 1. Vitamins Deficiencies of several vitamins are known to be associated with irritability. These include niacin,4 pantothenic acid,5 thiamine,6 vitamin B67 and vitamin C.8 In industrialized societies, the classic vitamin deficiency diseases are rare, although marginal vitamin nutriture due either to inadequate intake or to vitamin dependency appears to be fairly common. Moreover, under laboratory conditions, adverse behavioral changes precede specific clinical findings in a number of vitamin deficiencies.9 It is not known how frequently overaggressive behaviors are a manifestation of marginal vitamin nutriture. While little has been published to prove a relationship between the aggressive behavioral syndrome in humans and marginal vitamin nutriture, Lonsdale and Shamberger, writing in The American Journal of Clinical Nutrition, reported on twenty people eating "junk food" diets who were found to have biochemical evidence of marginal thiamine deficiency. Their subjects, and particularly the adolescents, were impulsive, highly irritable, aggressive and sensitive to criticism. Following thiamine supplementation, their behavior improved concurrent with laboratory evidence of improved thiamine nutriture, suggesting that marginal thiamine deficiency may have contributed to their aggressive behavioral syndrome.6 Hopefully, well-controlled studies will eventually provide a clearer picture of the importance of marginal vitamin deficiencies in promoting overaggressive behaviors. 2. Minerals Note: for the sake of completeness, minerals which do not function as nutrients are included in this review. Iron The most common nutritional deficiency in industrialized societies, 10% of American males and 3% of American females are overtly iron-deficient (ferritin less than 10 mg/mL.10 A deficiency of iron is known to interfere with proper brain function. Dopamine is a major neurotransmitter in the brain, iron is highly concentrated in the dopamine pathways, and animal studies have shown that iron deficiency may cause learning deficits and consequent behavioral impairment by diminishing dopamine neurotransmission.11 Iron is also needed as a co-factor for the enzymes which metabolize not only dopamine, but also serotonin and norepinephrine, which also have a potent influence on behavior. Evidence is now emerging that iron deficiency may be an important contributor to the aggressive behavioral syndrome. Among adolescent males, iron deficiency has been shown to be directly associated with aggressive behavior (Conduct Disorder).12 Moreover, in a population of incarcerated adolescents, the prevalence of iron deficiency was nearly twice that found in their non-incarcerated peers.13 Lithium There is considerable evidence that pharmacologic doses of lithium, which has no known essential function, can reduce abnormal aggressive behaviors including self-mutilation.14 Lithium has been used successfully with treatment-resistant hospitalized children with diagnoses of Conduct Disorder, Aggressive Type,15 as well as with brain-injured16 and mentally retarded17 patients with aggressive, combative or self-destructive behavior. While often effective, lithium at pharmacologic doses (generally 900,000 micrograms or more daily) has serious limitations. It suffers from many potential side effects, some of which are common. Because it becomes toxic at a serum level which is not much higher than the therapeutic range, serum lithium levels must be tested periodically. For these reasons, patients must be under medical supervision so long as they are taking the drug. It is possible that lithium may exert a powerful effect on overaggressive behaviors at far lower levels of intake. Using data from 27 Texas counties, Schrauzer and Shrestha found that the incidences of suicide, homicide and rape were significantly higher in counties whose drinking water supplies contained little or no lithium than in counties with higher water lithium levels, even after correcting for population density. Corresponding associations with the incidences of robbery, burglary and theft were also significant, as were associations with the incidences of arrests for possession of opium, cocaine and their derivatives. Only the incidences of arrests for possession of marijuana, driving under the influence of alcohol, and drunkenness failed to correlate with the water lithium level.18 While the effect of low-dose lithium supplementation on overaggressive behaviors has not been reported, results of an uncontrolled study suggest that low-dose lithium derived from vegetable concentrates may have a powerful effect on mental state and behavior. Thirteen depressed patients with bipolar disorder were treated with natural lithium derived from vegetable concentrates. All improved in about ten days and there were no adverse effects. After six weeks, they were taken off of lithium and all regressed to their former depressed state within three days. Two days after lithium was resupplied, their depressions lifted again.19 If we assume that a person consumes about one liter of water daily from municipal supplies, it is striking that the level of lithium provided from the vegetable concentrates approximates that consumed by residents of the Texas counties with higher lithium levels: "Natural" lithium dosage - 150 micrograms daily; Lithium level of drinking water in the Texas counties with higher levels18 - 70-170 micrograms per liter. Magnesium Rodent studies suggest that magnesium has a complex relationship with aggressive behaviors. Magnesium deficiency reduces offensive aggressive behavior but increases defensive aggressive behavior.20 Lower levels of magnesium supplementation increase the number of attacks on intruders while higher levels have the opposite effect.21 In humans, magnesium deficiency, which enhances catecholamine secretion and sensitivity to stress, may promote aggressive behavior. Increased catecholamines, in turn, induce intracellular magnesium losses and, eventually, increased urinary losses of magnesium.22 It has been suggested that the Type A behavior pattern - which is associated with chronic stress and aggressive behavior - may both cause and be caused by magnesium deficiency.22 Also, suicide attempts, which are violently aggressive acts against the self, have been correlated with lowered magnesium levels in the cerebrospinal fluid.23 Manganese Manganese is an essential trace mineral. Massive overexposure produces "manganese madness" which may initially be marked by violence, criminal acts and a state of mental excitement; later, neurological impairment slowly develops, with signs and symptoms which resemble Parkinson's disease. The behavioral effects of marginal levels of manganese toxicity have not been described. Recently, Gottschalk and his associates consistently found elevated hair manganese in a population of violent male offenders, suggesting that marginal manganese toxicity may be associated with violent criminal behavior. Compared to the hair manganese levels which they found, people exposed to levels of manganese pollution which are known to be toxic possess hair values that are two to six times higher.24 Elevated hair manganese levels have also been reported in hyperkinetic children,25, 26 and men with a history of childhood hyperactivity have an increased rate of antisocial and drug use disorders.27 In rats, chronic manganese exposure initially produces hyperactivity with an increased tendency to fight.28 While any hypothesis concerning the behavioral effects of marginal manganese toxicity in humans is highly speculative, these findings suggest that marginal manganese toxicity may promote overaggressive behaviors in adults. Heavy Metals Brain damage due to toxic metal exposure may promote aggressive, antisocial and violent behaviors. Lead exposure is known to cause learning and behavioral problems, problems which are found in a substantial portion of juvenile delinquents. The strongest evidence to date that lead exposure increases the frequency of aggressive behaviors comes from the Edinburgh Lead Study which included over 500 children between the ages of 6 and 9. After taking 30 possible confounding variables into account, the investigators still found a significant relationship between the log of blood lead levels and teachers' ratings of the childrens' behavior on an "aggressive/antisocial" scale and on a "hyperactive" scale, but not on a "neurotic" scale. As in other studies on the relationship between lead exposure and brain damage, a dose-response relationship was found between blood lead and behavior ratings, with no evidence of a threshold.29 Pihl and associates have addressed the relationship of lead exposure and violent behavior in adults. Hair lead levels from 19 violent criminals were found to be elevated as compared with those of 10 nonviolent criminals.30 This study was repeated 8 years later by the same research team with essentially the same results. However, their results were contradicted by those of the recent Gottschalk study on hair manganese levels; in that study, no significant differences were found between hair lead levels of 104 violent criminals, prison guards and local townspeople.24 As with lead, studies comparing hair cadmium levels of violent male offenders to matched controls have had conflicting results. One study published in the Journal of Learning Disabilities looked at hair cadmium levels of 40 apparently normal young men entering US Navy recruit training and found a highly significant relationship between hair cadmium levels and the number of demerits each recruit had received. Moreover, the three recruits who had the highest cadmium levels all displayed serious behavior difficulties during training.31 Exposure to aluminum may also contribute to overaggressive behaviors. Hair aluminum levels of a group of 22 juvenile offenders,32 as well as of another group of 10 severely delinquent, psychotic or prepsychotic adolescent boys,33 were elevated. However, both studies compared aluminum levels to laboratory norms rather than to matched controls; thus other differences between the groups could account for the findings. 3. Amino Acids Tryptophan Serotonin, a major neurotransmitter, has been found to play an important role in modulating aggressive behavior. Impulsive, violent and suicidal behaviors have repeatedly been shown to be associated with a reduction in serotonergic activity in the central nervous system.34 Tryptophan, an essential amino acid, is the dietary precursor to serotonin, and several lines of evidence have suggested that the amount of tryptophan in the diet relates closely to aggressive behavior. For example, rats given a diet almost lacking in tryptophan develop aggressive behavior towards mice.35 Tryptophan must compete with other large neutral amino acids to cross the blood-brain barrier; therefore the ratio of the amount of tryptophan to the amount of competing amino acids (the tryptophan ratio) may provide a rough indication of the availability of tryptophan in the brain for conversion into serotonin. Kitahara has calculated the dietary tryptophan ratio for 18 European countries to attempt to relate it to homicide rates. While initially no correlation was found between low tryptophan ratios and homicide, once social and cultural differences were controlled for, low tryptophan ratios were found to be associated with high homicide rates.36 A more direct method of examining the relationship between the tryptophan ratio and aggression is by measuring the actual ratio in the blood plasma. When a group of depressed alcoholics was evaluated in this manner, those with a history of aggression, including suicide attempts, also had the lowest tryptophan ratios.37 If a low ratio of tryptophan to competing amino acids is associated with aggressive behavior, will tryptophan supplementation reduce that behavior? Dietary tryptophan was manipulated in social groups of vervet monkeys by providing them with amino acid mixtures that were tryptophan-free, nutritionally balanced, or excessively high in tryptophan. These mixtures were shown to have a marked effect on plasma tryptophan levels. During spontaneous activity, the only effect of the different mixtures was increased aggression in the males on the tryptophan-free mixture. During competition for food, however, while the tryptophan-free mixture continued to increase male aggression, the high-tryptophan mixture reduced aggression in both males and females.38 These data suggest that tryptophan supplementation may be most effective in reducing aggression during times of stress. When hospitalized male schizophrenics were given tryptophan, only those patients with high levels of hostility and a high lifetime frequency of aggressive incidents benefited; these patients showed a lessening of hostility and depression, a reduction in ward incidents and improvement on a standardized psychiatric rating scale.39 In another study of twenty aggressive patients, 6 g of tryptophan daily for one month failed to reduce the number of violent incidents, although it significantly reduced the need for potent medications to control violent or agitated behavior.40 The rate of firing of serotonergic neurons in the brain increases as the level of behavioral arousal increases; thus increased serotonin levels would be more likely to influence brain function at higher levels of arousal. Indeed, this fact probably explains why the vervet monkeys only responded to tryptophan supplementation when they were put under competitive stress. It also may explain why altered tryptophan levels failed to affect aggression in a study of normal human males, while overaroused, hostile and aggressive psychiatric patients responded well. In the conversion of tryptophan to serotonin, the intermediate step is its conversion to 5-hydroxytryptophan. Surprisingly, supplementation with 5-hydroxytryptophan may increase aggressive behavior, apparently because, while tryptophan appears to enhance the serotonergic system exclusively, 5-hydroxytryptophan also appears to enhance the catecholaminergic system.41 4. Reactive Hypoglycemia There is early evidence that hypoglycemia during glucose tolerance testing is related to hostile, aggressive behavior such as that seen in habitually violent and impulsive criminals.34 Virkkunin, for example, found that a group of habitually violent adult criminals had lower basal glucose levels during glucose tolerance testing than controls.42 Even in the normal population, there is evidence of a relationship between hypoglycemic tendencies and both frustration and hostility.43 Assuming that there is an association between hypoglycemia and the aggressive behavioral syndrome, the question of whether hypoglycemia causes the syndrome remains. One method of investigating the issue of causality is by changing the amount of sugar in the diet and examining the behavioral effects. Since dietary sugar provokes insulin production which may cause a reactive hypoglycemia, a change in behavior following a change in sugar intake would be consistent with the hypothesis that dietary sugar influences that behavior. In a series of increasingly sophisticated double-blind studies, Schoenthaler addressed this question by reducing the sugar intake of thousands of incarcerated juvenile offenders in different locations around the United States. Compared to offenders on a placebo diet, he found a significant reduction in various forms of antisocial behavior (such as assaultiveness, fighting, self-injury and suicide attempts) in offenders restricted to a minimal amount of sugar in their diet - but only for the males.44 While Schoenthaler's work suggests that dietary sugar may influence behavior, he did not examine blood sugar levels; it thus fails to address the role of reactive hypoglycemia in the aggressive behavioral syndrome. The finding that only males responded may either be because males are more likely to engage in aggressive behaviors, or because males are more sensitive to nutritional influences on aggression. (Remember that the lack of tryptophan in the diet only increased aggression during spontaneous play in the male monkeys.) Further studies are needed to address these important questions. 5. Food Sensitivities It appears that overaggressive behaviors can be provoked by a reaction to common foods. Reactions range from irritability to a psychotic aggressive reaction. Children who improved after food eliminations had previously been irritable, fretful, quarrelsome and could not get along with others. Often they had to be taken out of school as they upset the classes and were considered incorrigible. After food eliminations, however, their personalities dramatically changed, and they became happy and social.45 A study reported in the Lancet suggests that food sensitivities may be quite common among behaviorally- disturbed children. Eighty-one out of a group of 140 children with behavior disorders (almost two-thirds) experienced significant improvement following the elimination of certain foods along with food additives. When they were challenged with the specific foods which had been eliminated, their behavior problems returned. Moreover, 75% of these children reacted to a double-blind challenge with salicylates but not to placebo.46 The following case study, reported in Psychology Today, illustrates how food sensitivities may affect aggressive behavior: When he was five years and one month old, G.L. was seen because of uncontrollable temper tantrums. He was believed aphasic because of poor speech development, and was too uncomfortable to do initial IQ testing. The EEG showed 14-per-second spikes, large amounts of sharp activity in the motor leads, temporal single, polyphasic sharp waves, and a long run of sharp waves in the right temporal area. Allergy tests revealed strong reactions to milk, chocolate and yeast. He was placed on a diet free of milk, chocolate, and cola drinks. Seven and one half months later, his EEG was normal. Six months after the repeat EEG, he was learning better and his behavior was much improved. He was challenged again with the suspected foods for one week, during which time his behavior again became uncontrollable. The EEG now showed two-and-one-half to six-per-second activity on the right, greater in the mid-temporal and parietal leads, accentuated by drowsiness. Light cerebral dysfunction was diagnosed.47 Adults may also display overaggressive behaviors due to food sensitivities. For example, MacKarness has written of a woman who had been hospitalized thirteen times for violent behavior and depression; after common foods were eliminated from her diet, she no longer became violent or depressed. Instead she felt fine and obtained a regular job.48 While the research literature suggests that any commonly ingested food or food additive may be responsible for provoking pathological psychological and behavioral reactions, milk may be a special case. Schauss and Simonsen found that chronic juvenile delinquents consumed much more milk than matched controls without a history of delinquency. The male offenders consumed an average of a gallon of milk daily compared to a little less than a quart a day for the controls, and the females showed similar differences.49 Schauss believes that overconsumption of milk causes antisocial behavior. He has reported that, when several Michigan detention centers reduced their inmates' milk consumption, the incidence of antisocial behavior declined; when they permitted milk consumption to increase again, antisocial behavior also increased.50 Discussion and Summary The literature offers numerous clues, but little scientific verification, consistent with the hypothesis that the aggressive behavioral syndrome can be prevented and treated by manipulating nutritional factors. Epidemiological studies have repeatedly found associations between overaggressive behaviors and deficiencies of several essential nutrients: niacin, pantothenic acid, thiamine, vitamin B6, vitamin C, iron, magnesium and tryptophan. While repletion of frank deficiencies is likely to be beneficial, the benefit of correcting marginal deficiencies remains to be proven. Not an essential nutrient, lithium has been proven effective in reducing overaggressive behaviors when provided at massive pharmacologic dosages. Moreover, even the relatively tiny daily lithium intake from municipal water supplies has been found to be negatively correlated with measures of the aggressive behavioral syndrome. In an open trial, supplementation with such natural levels of lithium appeared to be effective in treating bipolar depression. These findings suggest that natural lithium supplementation may be effective in the management of the aggressive behavioral syndrome, a hypothesis which remains to be explored experimentally. There is some evidence that overaggressive behaviors may be promoted by the toxic effects of aluminum, cadmium and lead. Exposures to these elements (especially cadmium and lead) should be avoided; it is unknown whether treatments designed to chelate these metals in order to remove them from the brain are effective in reducing overaggressive behaviors. Reactive hypoglycemia may be more common among people displaying the aggressive behavioral syndrome and, in an open study, reducing sugar consumption was followed by a reduction in antisocial behavior. Whether treating documented reactive hypoglycemia reduces overaggressive behaviors remains unknown. Finally, sensitivities to foods and food additives appear capable of inducing overaggressive behaviors. Most of the evidence remains anecdotal; however, salicylates have been shown to provoke behavioral disturbances under double-blind conditions. Despite the relative paucity of scientific evidence from controlled studies, clues from case reports, open trials, observational (correlational) studies and animal studies suggest that attention to nutritional factors may reduce overaggressive behaviors and the devastation resulting from them. Those clues, plus the safety of most nutritional interventions, argue that a nutritional approach should be considered in the treatment of the aggressive behavioral syndrome. References 1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, D.C., American Psychiatric Association, 1987. 2. Hanes: Health and Nutrition Examination Survey. U.S. Dept. of HEW Publication No. (HRA) 74-1219-1, Rockville, MD, 1974. 3. Tucker DM et al: Nutrition status and brain function in aging. Am. J. Clin. Nutr. 52:93-102, 1990. 4. Gelenberg AJ: Psychiatric Disorders, in DM Paige, Ed. Clinical Nutrition, Second Edition. St. Louis, The C.V. Mosby Company, 1988. 5. Hodges RE et al: J. Clin. Invest. 38:1421, 1959. 6. Lonsdale D, Shamberger R: Red cell transketo-lase as an indicator of nutritional deficiency. Am. J. Clin. Nutr. 33(2):205-11, 1980. 7. McLaren DS: Clinical manifestations of nutritional disorders, in ME Shils & VR Young. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 8. Wilmot CA et al: Ascorbic acid inhibits isolation-induced fighting in mice. Fed. Proc. 42:1160, 1983. 9. Brin M: Examples of behavioral changes in marginal vitamin deficiency in the rat and man, in J. Brozek, Ed. Behavioral Effects of Energy and Protein Deficits. United States Department of Health, Education and Welfare Publ. no. (National Institute of Health) 79-1906, 1979. 10. Baily L, Gensburg J, Wagner P et al: Serum ferritin as a measure of iron stores in adolescents. J. Pediatr. 101:774-6, 1982. 11. Youdim MB et al: Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am. J. Clin. Nutr. 50(3 Suppl.):607-15, 1990. 12. Webb TE, Oski FA: Behavioral status of young adolescents with iron deficiency anemia. J. Special Ed. 8(2):153-6, 1974. 13. Rosen GM, Deinard AS, Schwartz S et al: Iron deficiency among incarcerated juvenile delinquents. J. Adolesc. Health Care 6:419-23, 1985. 14. Wickham EA, Reed JV: Lithium for the control of aggressive and self-mutilating behavior. Int. Clin. Psychopharmacol. 2(3):181-90, 1987. 15. Campbell M et al: Behavioral efficacy of halo-peridol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch. Gen. Psychiatry 41(7):650-6, 1984. 16. Glenn MB et al: Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am. J. Phys. Med. Rehabil. 68(5):221-6, 1989. 17. Spreat S et al: Lithium carbonate for aggression in mentally retarded persons. Comp. Psychiatry 30(6):505-11, 1989. 18. Schrauzer GN, Shrestha KP: Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biol. Trace Elem. Res. 25(2):105-13, 1990. 19. Fierro AA: Natural low dose lithium supplementation in manic-depressive disease. Nutr. Perspectives January, 1988:10-11. 20. Kantak KM: Magnesium deficiency alters aggressive behavior and catecholamine function. Behav. Neurosci. 102(2):304- 11, 1988. 21. Izenwasser SE et al: Stimulant-like effects of magnesium on aggression in mice. Pharmacol. Biochem. Behav. 25(6):1195-9, 1986. 22. Henrotte JG: Type A behavior and magnesium metabolism. Magnesium 5:201-10, 1986. 23. Banki CM et al: Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol. Psychiatry 20(2):163-71, 1985. 24. Gottschalk LA et al: Abnormalities in hair trace-elements as indicators of aberrant behavior. Compr. Psychiatry 32:229-37, 1991. 25. Barlow PJ: A pilot study on the metal levels in the hair of hyperactive children. Med. Hypotheses 11(3):309-18, 1983. 26. Collipp PJ: Manganese in infant formulas and learning disability. Ann. Nutr. Metab. 27:488-94, 1983. 27. Mannuzza S et al:P Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch. Gen. Psychiatry 48:77- 83, 1991. 28. Chandra SV: Psychiatric illness due to manganese poisoning. Acta Psychiatr. Scand. Suppl. 303:49-54, 1983. 29. Thomson GO et al: Blood-lead levels and children's behaviour: results from the Edinburgh Lead Study. J. Child Psychol. Psychiatry 30(4):515-28, 1989. 30. Pihl RO et al: Hair element content of violent criminals. Can. J. Psychiatry 27:533, 1982. 31. Struempler RE et al: Hair mineral analysis and disruptive behavior in clinically normal young men. J. Learn. Disabil. 18(10):609-12, 1985. 32. Schmidt K et al: Clinical ecology treatment approach for juvenile offenders. J. Behav. Ecology: Biosocial 2(1), 1981. 33. Rees EL: Aluminum toxicity as indicated by hair analysis. J. Orthomol. Psychiatry 8:37, 1979. 34. Roy A et al: Monamines, glucose metabolism, aggression towards self and others. Int. J. Neurosci. 41(3-4):261-4, 1988. 35. Giammanco S et al: Short term diet of precooked corn meal almost lacking in tryptophan and interspecific rat-mouse aggressive behavior. Arch. Int. Physiol. Biochim. 98(1):23-6, 1990. 36. Kitahara M: Dietary trypotophan ratio and homicide in Western and Southern Europe. J. Orthomol. Med. 1(1):13-6, 1986. 37. Branchey L et al: Depression, suicide and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res. 12(3):219-26, 1984. 38. Chamberlain B et al: The effect of raising or lowering tryptophan levels on aggression in vervet monkeys. Pharmacol. Biochem. Behav. 28(4):503-10, 1987. 39. Morand C et al: Clinical response of aggressive schizophrenics to oral tryptophan. Biol. Psychiatry 18(5):575-8, 1983. 40. Volavka J et al: Tryptophan treatment of aggressive psychiatric patients. Biol. Psychiatry 28(8):728-32, 1990. 41. Raleigh MJ: Differential behavioral effects of tryptophan and 5-hydroxytryptophan on vervet monkeys: influence of catecholaminergic systems. Psychopharmacology (Berlin) 93(1):44-50, 1987. 42. Virkkunen M: Reactive hypoglycemia tendency among habitually violent offenders: A further study by means of the oral glucose tolerance 43. Benton D et al: Mild hypoglycaemia and questionnaire measures of aggression. Biol. Psychol. 14(1-2):129-35, 1982. 44. Schoenthaler SJ: Int. J. Biosocial Res. Vol. 3-5, 1982-3. 45. Clarke TW: The relation of allergy to character problems in children: A survey. Ann. Allergy March-April, 1950, pp. 175- 87. 46. Swain A et al: Salicylates, oliogoantigenic diets, and behaviour. Letter. Lancet 2:41-2, 1985. 47. Moyer KE: Allergy & aggression: The physiology of violence. Psychol. Today July, 1975, pp. 77-9. 48. MacKarness R: Eating Dangerously. New York, Harcourt, Brace, Jovanovich, 1976. 49. Schauss AG, Simonsen CE: Critical analysis of the diets of chronic juvenile offenders: Part I. J. Orthomol. Psychiatry 8(3):149-57, 1979. 50. Schauss AG: Nutrition and antisocial behaviour. Int. Clin. Nutr. Rev. 4(4):172-7, 1984.

Labels: , , , , , , , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Supplements for ADHD DATE: 8/30/2007 05:45:00 PM ----- BODY:
ADD & ADHD ADD & ADHD Natural Control of ADD & ADHD Billie J. Sahley, Ph.D., CNC In Toxic Psychiatry, Peter Breggin, MD states, Hyperactivity is the most frequent justification for drugging children. Difficult-to-control children are certainly not a new phenomenon, but attempts to give them a medical diagnosis are the product of modern psychology and psychiatry. At first, psychiatrists called hyperactivity a brain disease: minimal brain dysfunction (MBD). When no minimal brain dysfunction could be demonstrated, the label became attention deficit disorder (ADD). Six million children in this country suffer some type of learning disability, ADD, or ADD with hyperactivity (ADHD). Over two million children currently take Ritalin for ADD/ADHD. ADD and ADHD may be caused by psychological problems, including trauma and abuse, nutritional deficiencies, chemical imbalances, allergic responses to food and chemicals, or a poor diet. A failure in the brains inhibitory system (the ability of the brain to inhibit and control itself) may also cause ADD/ADHD. Ritalin, the most commonly used drug for ADD and ADHD, is an amphetamine and a Schedule II class drug (other Schedule II drugs are morphine, opium, and medicinal cocaine). Doctors prescribe Ritalin for many children who do not need it, causing a number of adverse mental and physical side effects. Yet this potent, toxic drug is being used as a quick fix to quiet children. Surprisingly, prescription rates for Ritalin doubled between 1992 and 1996. Children demonstrating symptoms of anxiety, ADHD or ADD often have an imbalance in their brains biochemistry. A biochemical imbalance results from a deficiency of neurotransmitters, the chemical messengers of the brain. If a biochemical imbalance goes untreated, a child can display maladaptive behavior, followed by possible long-term physical and emotional problems. A childs state of health reflects his or her state of nutrition. When minerals, vitamins, amino acids, enzymes, or even hormones are deficient in a childs system, the result can be a disturbed biochemical homeostasis causing impaired functions in the brain. This, in turn, can cause an inability to focus, concentrate, and stay on task. At the Pain and Stress Center in San Antonio, we have successfully treated numerous children with orthomolecular therapy. Orthomolecular therapy corrects the brains biochemical imbalance, without toxic drugs that can produce adverse side effects. ADD/ADHD presents a major problem facing parents today. Most people think of hyperactivity as some type of behavioral problem (a child who is impatient, impulsive, and constantly moving); but not all hyperactive children are aggressive. Some are very passive, withdrawn, and find it hard to communicate their feelings. ADD/ADHD is not a condition that can be measured in precise scientific terms. Nor is it a situation with a quick fix, especially with powerful and addictive drugs such as Ritalin. ADD/ADHD is a complex and intricate condition in which children demonstrate maladaptive or disorganized behaviors, which put them out of sync with the world around them. Numerous clinical studies established that hyperactive children often have low serotonin levels. A proper combination of tryptophan or 5-HTP and B6, elevates the serotonin level and balances the brain; the childs symptoms diminish. The dosage, of course, depends on the childs age, weight, and the degree of hyperactivity. Effectiveness of Amino Acids Neurotransmitters affect behavior and learning. A neurotransmitter deficiency consequently has a dramatic effect on childrens or adults abilities to learn and function in an orderly manner. Most hyperactive and ADD children are born with a shortage of neurotransmitters, establishing a genetic link, most often on the male side. These children also do not manufacture the needed amount of these chemical messengers. Where do we get neurotransmitters? From the amino acids, GABA, glycine, taurine, tyrosine, glutamine and tryptophan. Do children or adults get enough aminos through diet? NO! Balanced amino-acid doses, in the right combination and formulas, produce the needed neurotransmitters naturally. Using a stimulant medication to try to produce neurotransmitters is like a shotgun going off in the childs brain. Our children were not born with Ritalin in their brain, so how can they have a Ritalin deficiency? Approximately fifty different neurotransmitters exist in the human brain, but communication between brain cells uses only ten (approximately) major neurotransmitters. How we feed the brain directly affects our production of neurotransmitters. With proper nutrition and supplementation, we can correct or enhance mind, mood, memory, and behavior. All major neurotransmitters are made from amino acids and dietary protein. One of the dangers of a low-protein diet is not ingesting enough amino acids to make adequate brain neurotransmitters. Apathy, lethargy, difficulty concentrating, loss of interest, and insomnia all result when the diet does not include adequate amounts of amino acids. Drugs do not produce or increase production of neurotransmitters. Drugs only address symptoms. Amino acids restore the balance nature intended. Some of the major symptoms of neurotransmitter deficiencies are ADD, ADHD, brain fog, mood swings, increased stress, anxiety, depression, insomnia, irritability, and aggression. Stress plays a major role in the depletion of neurotransmitters. Inhibitory neurotransmitters are the keys to behavior, emotions, and pain. Inhibitory amino acids include tryptophan, taurine, GABA, and glycine. Millions of people have turned to drugs known as SSRIs (Selective Serotonin Reuptake Inhibitors). These drugs, such as Prozac, Paxil, Zoloft, and Effexor work by selective enhancement of serotonin levels. SSRIs prevent the presynaptic nerve from reabsorbing serotonin that it previously secreted. Prozac causes an increase in brain serotonin levels; but Prozac and other prescription drugs do not increase neurotransmitters. (See Figure 1). 5-HTP is synergistic with other supplements that enhance neurotransmitters such as GABA, glutamine, tyrosine, phenylalanine, and glycine. Magnesium prolongs the benefits of 5-HTP. Chronic stress depletes available serotonin, as well as interferes with serotonins ability to control behavior. Research demonstrates that low serotonin levels can change brain function and impair learning. Low serotonin may be responsible for an increase in depression and drug use among teens and children. Most teens with low serotonin levels are more prone to try recreational drugs or even prescription drugs, for relief. A low brain serotonin level impairs the ability to focus and reason. 5-HTP shows a lot of promise as a natural answer to a multitude of problems that plague adults and children. Use caution with 5-HTP if your child is taking prescription antidepressant medications. GABA (Gamma-aminobutyric acid) GABA, an inhibitory neurotransmitter, is found throughout the central nervous system. GABA assumes an ever-enlarging role as a significant influence on ADD, ADHD, stress, anxiety, and depression, as well as stress-induced illnesses. According to Candace Pert, a neuroscientist who discovered the GABA receptor, every cell in the body has a GABA receptor, which is one reason why GABA has such positive effects. GABA inhibits the cells from firing, diminishing anxiety-related messages. Tranquilizers provide only temporary relief. We have seen many patients on Xanax that still experience anxiety. They have been told it is not addictive: it is! THERE IS NO SUCH THING AS A TRANQUILIZER DEFICIENCY! Nutrient deficiencies do occur, however; and they can and do change behavior. GABA, glutamine, and glycine prove vital for energy and the smooth running of brain functions. We have successfully used these three amino acids with patients to ease anxiety, irritability, and ADD. Research demonstrates a large number of children who display ADD/ADHD behavior actually experience anxiety. If they use all available GABA, then the receptors in the brain become empty, allowing the brain to be bombarded with random firings of excitatory messages. However, when adequate amounts of GABA are present, the reception of multiple random firings are blocked, so the brain does not become overwhelmed. At the Pain & Stress Center we regularly combine GABA and other amino acids to achieve positive results. Dose amounts vary, depending on the age and weight of the child. GABA now takes its place as a major influence on those taking drugs, and in many cases, replacing the drugs. We have found that, when combined with other amino acids, GABA works exceptionally well with ADD children. L-Glutamine Glutamine, along with GABA and Glycine, is rapidly becoming an important therapeutic amino acid of the 21st century. Glutamine, found in many foods, is the third most abundant amino acid in the blood and brain. It also provides a major alternative fuel source for the brain when blood sugar levels are low. Glutamine functions as an inhibitory neurotransmitter, and is the precursor for GABA, the antianxiety amino acid. The amino acid trio of Glutamine, GABA, and Glycine plus B6 are among the major inhibitory neurotransmitters in the brain. Glutamine is found in the nerves of the hippocampus, the memory center of the brain, in the cranial nerves, and in many other areas of the brain. These three amino acids work together as inhibitory neurotransmitters. Anyone taking amino acids must take B6 to metabolize the amino acids. Intellectually impaired children and adults often show an increase in IQ after taking glutamine in combination with Ginkgo biloba and B6. Dr. Roger Williams demonstrated that children and adults diagnosed with ADHD showed a marked improvement when taking 250 mg to 1,000 mg of glutamine daily. GABA and glutamine are not only found in the brain, but also in the receptor sites throughout the body. Glutamine is the memory and concentration amino acid. Seventy five percent of hyperactive and ADD childrens blood tests showed low levels of glutamine. Dr. C. Fredericks research also demonstrated a definite increase in the IQs of children given glutamine. When glutamine was given daily, children showed impressive improvements in their abilities to learn, to retain, and to recall. Glutamine is a major part of my orthomolecular program for hyperactive and ADHD children. Glutamine is one of the amino acids that create the neurotransmitters in the brain that enhance learning and memory. Hyperactive and ADD children have low neurotransmitter levels, especially glutamine. Adding glutamine increases the level of neurotransmitters. Start with 500 mg of glutamine and gradually increase until you reach the optimal dose for your child, to a maximum of 3,000 mg per day. Taurine Taurine is now classified as a conditionally essential amino acid in the adult. In infants and children, however, taurine is an essential amino acid. As one of the sulfur amino acids, adults synthesize taurine from cysteine and methionine, provided B6 and zinc are present. Taurine is found abundantly throughout the body in the heart, olfactory bulb, central nervous system, and brain (hippocampus and pineal gland). As an inhibitory neurotransmitter, taurine, after GABA, is the second-most important inhibitory transmitter in the brain. Taurines inhibitory action in the brain equals that of GABA and glycine. Its inhibitory effect is one source of taurines anticonvulsant and antianxiety properties. Some children with Downs syndrome have shown an increase in IQ levels when taurine was added to their diet along with glutamine, B6, and vitamin E. The need for taurine increases whenever you experience more stress than usual, or have an illness. Tyrosine Tyrosine is the amino acid and inhibitory neurotransmitter that often helps overcome depression. Clinical studies show that tyrosine controls medication-resistant depression. In a 1980 issue of the American Journal of Psychiatry, a study by Dr. Alan Gelenberg of Harvard Medical School discussed the role of tyrosine in the control of anxiety and depression. Dr. Gelenberg postulated that the lack of available tyrosine results in deficiency of the hormone norepinephrine at a specific location in the brain that relates to mood problems such as depression. Children given tyrosine supplementation demonstrated a marked improvement in mental performance and mood stability. Tyrosine, because of its role in assisting the body to cope physiologically with stress and building the bodys natural store of adrenaline, deserves to be called the stress amino acid. Stress exhaustion requires tyrosine. During periods of stress, in order to continue coping with stress physiologically, the brain requires tyrosine. Tyrosine aids children and young teens, as well as adults, with recurrent depression and mood disorders. In children, dosage ranges from 200 to 500 mg daily. Glycine Glycine is a nonessential amino acid, with the simplest structure of all the amino acids resembling glucose (blood sugar) and glycogen (excess sugar converted in the liver for storage). Glycine is sweet to the taste, can be used as a sweetener, and can mask bitterness and saltiness. Pure glycine dissolves readily in water. As the third major inhibitory neurotransmitter in the brain, glycine readily passes the blood-brain barrier. Studies by the late Carl Pfeiffer, MD, Ph.D., demonstrated glycine as an important factor in psychiatric disorders. Glycine decreases the craving for sugar, and, in many cases, can replace sugar on foods such as cereal. Glycine calms aggression in both children and adults. When combined with GABA and glutamine, glycine influences brain function by slowing down anxiety-related messages from the limbic system. As a very nontoxic amino acid, both children and adults can use glycine. Glycine can be mixed with other amino acids. Doses for a child range between 500 to 2,000 mg daily, divided. Magnesium Hyperactive or ADD children are almost always deficient in magnesium. Magnesium proves necessary for proper brain energy and is the first mineral depleted when anyone (child or adult) is under stress. Magnesium is a stress mineral, and deficiency can lead to hyperactive or ADD behavior. Magnesium plays a significant role in sugar metabolism and in the proper utilization of carbohydrates to create energy. Magnesium is so very important in a childs diet, especially if he displays hyperactive behavior, ADD, or other behavioral problems. Magnesium can be taken in liquid form, tablet, or capsule. When added to the ADD/ADHD diet, calming effects sometimes occur immediately. Most magnesium exists inside the cells where it activates enzymes necessary for the metabolism of carbohydrates and amino acids. In 1988, a study published in Alternative Medicine Review linked the development of ADHD to low blood-serum magnesium levels. A group of children followed for six months were given 200 mg of magnesium a day. Researchers noted remarkably decreased hyperactivity in the children. As a major nutrient needed by ADD/ADHD children and adults, magnesium is the number one stress mineral needed by the body. Magnesium is responsible for over three hundred enzyme functions. It cannot be stored by the body, and it must be taken daily. Symptoms of magnesium deficiency include asthma, migraines, eye twitches, anxiety, confusion, muscle spasms, irritability, depression, nervousness, fatigue, mood swings, PMS, hypertension, and insomnia. Calcium A calcium deficiency can also induce ADD/ADHD behavior. A child deficient in calcium exhibits irritability, sleep disturbances, anger, and inattentiveness. The first signs of a calcium deficiency include nervous stomach, cramps, tingling in the arms and legs, and painful joints. A calcium deficiency can also lead to ADD/ADHD behavior. Children sensitive to dairy products must receive daily calcium supplementation in capsule, chewable, or liquid form. Children up to 10 years of age need 1000 mg of calcium daily; adolescents need 1,200 to 1,500 mg daily. For those involved in sports activities, calcium supplementation is a must. Huperzine Recent research reports that Huperzine A improves mental function and learning in adolescents. Chinese researchers designed a study to determine the efficiency of Huperzine on memory and learning. The clinical study included 34 matched pairs of junior middle school students that had significant complaints of poor memory and difficulty in learning. In the double blind trial, half of the students received a placebo while the other half received Huperzine A for four weeks. Academic performance was measured before and after the clinical trial. The Huperzine group scored significantly better on standard memory tests without side effects. Huperzine A is an extract derived from Chinese club moss. Huperzine can be combined with amino acids and other nutrients. The suggested dosage is one 50 mcg capsule in the morning and in the evening for children aged 12 and over. This information is excerpted from my book Control Hyperactivity/ADD Naturally. Other resources include Is Ritalin Necessary? Both are available through: Pain & Stress Center 5282 Medical Dr. #160 San Antonio, TX 78229-6023

Labels: , , , , , , , , , , , ,

----- -------- /* ----------------------------------------------- Blogger Template Style Name: Son of Moto (Mean Green Blogging Machine variation) Designer: Jeffrey Zeldman URL: www.zeldman.com Date: 23 Feb 2004 ----------------------------------------------- */ /* Primary layout */ body { margin: 0; padding: 0; border: 0; text-align: center; color: #554; background: #692 url(http://www.blogblog.com/moto_son/outerwrap.gif) top center repeat-y; font: small tahoma, "Bitstream Vera Sans", "Trebuchet MS", "Lucida Grande", lucida, helvetica, sans-serif; } img { border: 0; display: block; } /* Wrapper */ @media all { #wrapper { margin: 0 auto; padding: 0; border: 0; width: 692px; text-align: left; background: #fff url(http://www.blogblog.com/moto_son/innerwrap.gif) top right repeat-y; font-size:90%; } } @media handheld { #wrapper { width: 90%; } } /* Header */ #blog-header { color: #ffe; background: #8b2 url(http://www.blogblog.com/moto_son/headbotborder.gif) bottom left repeat-x; margin: 0 auto; padding: 0 0 15px 0; border: 0; } #blog-header h1 { font-size: 24px; text-align: left; padding: 15px 20px 0 20px; margin: 0; background-image: url(http://www.blogblog.com/moto_son/topper.gif); background-repeat: repeat-x; background-position: top left; } #blog-header p { font-size: 110%; text-align: left; padding: 3px 20px 10px 20px; margin: 0; line-height:140%; } /* Inner layout */ #content { padding: 0 20px; } @media all { #main { width: 400px; float: left; } #sidebar { width: 226px; float: right; } } @media handheld { #main { width: 100%; float: none; } #sidebar { width: 100%; float: none; } } /* Bottom layout */ #footer { clear: left; margin: 0; padding: 0 20px; border: 0; text-align: left; border-top: 1px solid #f9f9f9; background-color: #fdfdfd; } #footer p { text-align: left; margin: 0; padding: 10px 0; font-size: x-small; background-color: transparent; color: #999; } /* Default links */ a:link, a:visited { font-weight : bold; text-decoration : none; color: #692; background: transparent; } a:hover { font-weight : bold; text-decoration : underline; color: #8b2; background: transparent; } a:active { font-weight : bold; text-decoration : none; color: #692; background: transparent; } /* Typography */ #main p, #sidebar p { line-height: 140%; margin-top: 5px; margin-bottom: 1em; } .post-body { line-height: 140%; } h2, h3, h4, h5 { margin: 25px 0 0 0; padding: 0; } h2 { font-size: large; } h3.post-title { margin-top: 5px; font-size: medium; } ul { margin: 0 0 25px 0; } li { line-height: 160%; } #sidebar ul { padding-left: 10px; padding-top: 3px; } #sidebar ul li { list-style: disc url(http://www.blogblog.com/moto_son/diamond.gif) inside; vertical-align: top; padding: 0; margin: 0; } dl.profile-datablock { margin: 3px 0 5px 0; } dl.profile-datablock dd { line-height: 140%; } .profile-img {display:inline;} .profile-img img { float:left; margin:0 10px 5px 0; border:4px solid #8b2; } #comments { border: 0; border-top: 1px dashed #eed; margin: 10px 0 0 0; padding: 0; } #comments h3 { margin-top: 10px; margin-bottom: -10px; font-weight: normal; font-style: italic; text-transform: uppercase; letter-spacing: 1px; } #comments dl dt { font-weight: bold; font-style: italic; margin-top: 35px; padding: 1px 0 0 18px; background: transparent url(http://www.blogblog.com/moto_son/commentbug.gif) top left no-repeat; color: #998; } #comments dl dd { padding: 0; margin: 0; } .deleted-comment { font-style:italic; color:gray; } /* Feeds ----------------------------------------------- */ #blogfeeds { } #postfeeds { }

Adopt Biomed

This blog gathers information about biomedical interventions for children with adoption trauma and Reactive Attachment Disorder. Posts are gathered from multiple websites in one place. Most posts contain unedited text relating to biomedical treatment, dietary changes, vitamins, homeopathy, herbs, etc. Where possible, the link to the original information is included.

Thursday, January 15, 2009

Serotonin for ADHD

Serotonin May Be Better Target For ADHD Treatment Researchers at the Howard Hughes Medical Institute (HHMI) at Duke University have discovered that Ritalin and other stimulants exert their paradoxical calming effects by boosting serotonin levels in the brain. Elevating serotonin appears to restore the delicate balance between the brain chemicals dopamine and serotonin and calms hyperactivity, says HHMI investigator Marc Caron at Duke University Medical Center. Caron is an author of the study published in the January 15 issue of the journal Science. Attention deficit hyperactivity disorder (ADHD) affects three to six per cent of school-aged children. Symptoms include restlessness, impulsiveness, and difficulty concentrating. Stimulants commonly used to treat ADHD are so effective that "researchers haven't really taken the time to investigate how they work," says Caron. Previous dogma, says Caron, held that the calming action of Ritalin works through the neurotransmitter dopamine. Specifically, researchers believed that Ritalin and other stimulants interact with the dopamine transporter protein (DAT), a housekeeper of sorts for nerve pathways. After a nerve impulse moves from one neuron to another, DAT removes residual dopamine from the synaptic cleft-the space between two neurons-and repackages it for future use. Caron's team suspected that dopamine wasn't the only key to understanding ADHD, so they turned to mice in which they had "knocked out" the gene that codes for DAT. Since there is no DAT to "mop up" dopamine from the synaptic cleft, the brains of the mice are flooded with dopamine. The excess dopamine causes restlessness and hyperactivity, behaviors that are strikingly similar to those exhibited by children with ADHD. When placed in a maze that normal mice negotiate in less than three minutes, the knockout mice became distracted-performing extraneous activities such as sniffing and rearing - and they failed to finish in less than five minutes. The knockout mice also seemed unable to suppress inappropriate impulses - another hallmark of ADHD. Surprisingly, the knockout mice were still calmed by Ritalin, Dexedrine and other stimulants even though they lacked the protein target on which Ritalin and Dexedrine were thought to act. "That caused us to look for other systems that these stimulants might affect," says Caron. To test whether the stimulants interact with dopamine through another mechanism, the researchers administered Ritalin to the normal and knockout mice and monitored their brain levels of dopamine. Ritalin boosted dopamine levels in the normal mice, but it did not alter dopamine levels in knockout mice. That result implied that "Ritalin could not be acting on dopamine," says Caron. They then studied whether the stimulants altered levels of the neurotransmitter serotonin. The scientists administered Prozac - a well-known inhibitor of serotonin reuptake - to the knockout mice. After ingesting Prozac, the knockout mice showed dramatic declines in hyperactivity. "This suggests that rather than acting directly on dopamine, the stimulants create a calming effect by increase serotonin levels," Caron says. "Our experiments imply that proper balance between dopamine and serotonin are key," says Raul Gainetdinov, a member of Caron's research team. "Hyperactivity may develop when the relationship between dopamine and serotonin is thrown off balance." The brain has 15 types of receptors that bind to serotonin, and Gainetdinov is now trying to determine which specific serotonin receptors mediate the effects of Ritalin. The hope, says Caron, "is that we can replace Ritalin with a very specific compound that targets a single subset of receptors." While Prozac calmed hyperactivity in the knockout mice, Gainetdinov says that "Prozac isn't the best, because it isn't very selective." Caron and Gainetdinov are optimistic that a new generation of compounds that interact more specifically with the serotonin system will prove to be safer and more effective for treatments for ADHD.

Labels: , , ,

Serotonin's effects on multiple body systems

One Dangerous Deficiency Links IBS, Migraines, and More Health News By VRP Staff When you think of serotonin deficiency, the first consequence that might spring to mind is depression. And if so, you’d be right. But there’s more to this neurotransmitter than meets the eye—a lot more. Migraines, irritable bowel syndrome, fibromyalgia, obesity, even asthma… believe it or not, all of these serious conditions can be traced back to depleted serotonin levels. And the effects on your body can be as damaging as they are diverse. Serotonin is one of your brain’s most crucial messengers. It’s released by your neurons to send signals to other neurons, after which it’s returned to its original parent neuron to be reused. But if your levels are low, serotonin’s time on your synapse is cut short. It’s recaptured before it can finish its job—at a very high cost to your health, mentally and physically. In addition to depression, low levels of serotonin–and its precursor tryptophan–have been linked to binge eating, carbohydrate cravings, and weight gain.1 Studies show that obese and overweight diabetic patients have levels that are well below normal–and in clinical trials, increased brain serotonin led to both reduced caloric intake and resulting weight loss.2–4 But it’s not just your waistline that benefits from this critical neurotransmitter. Studies have shown that increasing serotonin levels can fight insomnia by improving sleep continuity.5 Research also shows that increased serotonin relieves migraines as effectively as standard drug therapy and aids in relief of chronic tension headaches.6–7 This same ability has made it a unique target in the treatment of fibromyalgia, with serotonin deficiency implicated for lower pain thresholds and higher clinical measures of perceived pain in patients.8–10 In an even more surprising connection, serotonin has also been identified as a major player in gut motility.11–12 Special serotonin–releasing cells can be found throughout your digestive system, responsible for stimulating peristaltic motion and pushing waste through your digestive tract.13 Even the development and severity of asthma has been linked to depression, anxiety, and low–serotonin related disorders—revealing yet another function under this neurotransmitter’s powerful influence.14 Proper levels of serotonin are essential for your health—and one way to ensure higher levels of this neurotransmitter is by boosting your intake of tryptophan, an essential amino acid found in high–protein foods that is responsible for serotonin synthesis in your brain. Research has shown that supplementing with tryptophan (and its metabolite 5–hydroxytryptophan, or 5–HTP) can replenish serotonin naturally and effectively—easing depression, anxiety, migraines, insomnia, and fibromyalgia symptoms in several clinical studies.15–17 References: 1. Gendall KA, Joyce PR. Meal–induced changes in tryptophan:LNAA ratio: effects on craving and binge eating. Eat Behav. 2000 Sep;1(1):53–62. 2. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty–four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003 May;77(5):1112–1118. 3. Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5–hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76(2):109–117. 4. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5–hydroxytryptophan. Am J Clin Nutr 1992 Nov;56(5):863–867. 5. Riemann D, Vorderholzer U. Treatment of depression and sleep disorders. Significance of serotonin and L–tryptophan in pathophysiology and therapy. Fortschr Med. 1998 Nov;116(32):40–42. 6. Titus F, Dávalos A, Alom J, Codina A. 5–Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol. 1986;25(5):327–329. 7. Ribeiro CA. L–5–Hydroxytryptophan in the prophylaxis of chronic tension–type headache: a double–blind, randomized, placebo–controlled study. For the Portuguese Head Society. Headache. 2000 Jun;40(6):451–456. 8. Birdsall TC. 5–Hydroxytryptophan: a clinically–effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271–280. 9. Hrycaj P, Stratz T, Muller W. Platelet 3Himipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1993;20:1986–1988. [letter] 10. Russell IJ, Michalek JE, Vipraio GA, et al. Platelet 3H–imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104–109. 11. Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008 Feb;4(1):41–48. 12. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Minneap). 1999 Jul 15;34(7):31–32,35–38,41–42. 13. Grider JR. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5–HT4 agonist tegaserod. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G319–G327. 14. Goodwin RD, Sourander A, Duarte CS, et al. Do mental health problems in childhood predict chronic physical conditions among males in early adulthood? Evidence from a community–based prospective study. Psychol Med. 2008 May 28:1–11. 15. Poldinger W, Calanchini B, Schwarz W. A functional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5–hydroxytryptophan and fluvoxamine. Psychopathology. 1991;24:53–81. 16. Kahn RS, Westenberg HG. L–5–hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord. 1985 Mar–Apr;8(2):197–200. 17. Puttini PS, Caruso I. Primary fibromyalgia and 5–hydroxy–L–tryptophan: a 90 day open study. J Int Med Res. 1992;20:182–189.

Labels: , , , , , ,

Tuesday, April 29, 2008

PTSD and neurobiology

The Body Keeps The Score:
Memory & the Evolving Psychobiology of Post Traumatic Stress
by Bessel van der Kolk


Bessel A. van der Kolk, MD.
Harvard Medical School
HRI Trauma Center
227 Babcock Street
Boston, MA 02146

This is a version of an article first published in the Harvard Review of Psychiatry, 1994, 1(5), 253-265. Note that this online version may have minor differences from the published version.
The author wishes to thank Rita Fisler, Ed.M. for her editorial assistance.
Background

For more than a century, ever since people's responses to overwhelming experiences were first systematically explored, it has been noted that the psychological effects of trauma are expressed as changes in the biological stress response. In 1889, Pierre Janet (1), postulated that intense emotional reactions make events traumatic by interfering with the integration of the experience into existing memory schemes. Intense emotions, Janet thought, cause memories of particular events to be dissociated from consciousness, and to be stored, instead, as visceral sensations (anxiety and panic), or as visual images (nightmares and flashbacks). Janet also observed that traumatized patients seemed to react to reminders of the trauma with emergency responses that had been relevant to the original threat, but that had no bearing on current experience. He noted that victims had trouble learning from experience: unable to put the trauma behind them, their energies were absorbed by keeping their emotions under control at the expense of paying attention to current exigencies. They became fixated upon the past, in some cases by being obsessed with the trauma, but more often by behaving and feeling like they were traumatized over and over again without being able to locate the origins of these feelings (2,3).

Freud also considered the tendency to stay fixated on the trauma to be biologically based: "After severe shock.. the dream life continually takes the patient back to the situation of his disaster from which he awakens with renewed terror.. the patient has undergone a physical fixation to the trauma"(4). Pavlov's investigations continued the tradition of explaining the effects of trauma as the result of lasting physiological alterations. He, and others employing his paradigm, coined the term "defensive reaction" for a cluster of innate reflexive responses to environmental threat (5). Many studies have shown how the response to potent environmental stimuli (unconditional stimuli-US) becomes a conditioned reaction. After repeated aversive stimulation, intrinsically non-threatening cues associated with the trauma (conditional stimuli-CS) become capable of eliciting the defensive reaction by themselves (conditional response-CR). A rape victim may respond to conditioned stimuli, such as the approach by an unknown man, as if she were about to be raped again, and experience panic. Pavlov also pointed out that individual differences in temperament accounted for the diversity of long term adaptations to trauma.

Abraham Kardiner(6), who first systematically defined posttraumatic stress for American audiences, noted that sufferers from "traumatic neuroses" develop an enduring vigilance for and sensitivity to environmental threat, and stated that "the nucleus of the neurosis is a physioneurosis. This is present on the battlefield and during the entire process of organization; it outlives every intermediary accommodative device, and persists in the chronic forms. The traumatic syndrome is ever present and unchanged". In "Men under Stress", Grinker and Spiegel (7) catalogue the physical symptoms of soldiers in acute posttraumatic states: flexor changes in posture, hyperkinesis, "violently propulsive gait", tremor at rest, masklike facies, cogwheel rigidity, gastric distress, urinary incontinence, mutism, and a violent startle reflex. They noted the similarity between many of these symptoms and those of diseases of the extrapyramidal motor system. Today we can understand them as the result of stimulation of biological systems, particularly of ascending amine projections. Contemporary research on the biology of PTSD, generally uninformed by this earlier research, confirms that there are persistent and profound alterations in stress hormones secretion and memory processing in people with PTSD.
The Symptomatology of PTSD

Starting with Kardiner(6), and closely followed by Lindemann (8), a vast literature on combat trauma, crimes, rape, kidnapping, natural disasters, accidents and imprisonment have shown that the trauma response is bimodal: hypermnesia, hyper-reactivity to stimuli and traumatic reexperiencing coexist with psychic numbing, avoidance, amnesia and anhedonia (9,10,11,12). These responses to extreme experiences are so consistent across traumatic stimuli that this biphasic reaction appears to be the normative response to any overwhelming and uncontrollable experience. In many people who have undergone severe stress, the post-traumatic response fades over time, while it persists in others. Much work remains to be done to spell out issues of resilience and vulnerability, but magnitude of exposure, prior trauma, and social support appear to be the three most significant predictors for developing chronic PTSD (13,14).

In an apparent attempt to compensate for chronic hyperarousal, traumatized people seem to shut down: on a behavioral level, by avoiding stimuli reminiscent of the trauma; on a psychobiological level, by emotional numbing, which extends to both trauma-related, and everyday experience (15). Thus, people with chronic PTSD tend to suffer from numbing of responsiveness to the environment, punctuated by intermittent hyperarousal in response to conditional traumatic stimuli. However, as Pitman has pointed out (16), in PTSD, the stimuli that precipitate emergency responses may not be conditional enough: many triggers not directly related to the traumatic experience may precipitate extreme reactions. Thus, people with PTSD suffer both from generalized hyperarousal and from physiological emergency reactions to specific reminders(9,10) The loss of affective modulation that is so central in PTSD mayhelp explain the observation that traumatized people lose the capacity to utilize affect states as signals (18). Instead of using feelings as cues to attend to incoming information, in people with PTSD arousal is likely to precipitate flight or fight reactions (19). Thus, they are prone to go immediately from stimulus to response without making the necessary psychological assessment of the meaning of what is going on. This makes them prone to freeze, or, alternatively, to overreact and intimidate others in response to minor provocations (12,20).
Psychophysiology

Abnormal psychophysiological responses in PTSD have been demonstrated on two different levels: 1) in response to specific reminders of the trauma and 2) in response to intense, but neutral stimuli, such as acoustic startle. The first paradigm implies heightened physiological arousal to sounds, images, and thoughts related to specific traumatic incidents. A large number of studies have confirmed that traumatized individuals respond to such stimuli with significant conditioned autonomic reactions, such as heart rate, skin conductance and blood pressure (20,21,22,23, 24,25). The highly elevated physiological responses that accompany the recall of traumatic experiences that happened years, and sometimes decades before, illustrate the intensity and timelessness with which traumatic memories continue to affect current experience (3,16). This phenomenon has generally been understood in the light of Peter Lang's work (26) which shows that emotionally laden imagery correlates with measurable autonomic responses. Lang has proposed that emotional memories are stored as "associative networks", that are activated when a person is confronted with situations that stimulate a sufficient number of elements that make up these networks. One significant measure of treatment outcome that has become widely accepted in recent years is a decrease in physiological arousal in response to imagery related to the trauma (27). However, Shalev et al (28) have shown that desensitization to specific trauma-related mental images does not necessarily generalize to recollections of other traumatic events, as well.

Kolb (29) was the first to propose that excessive stimulation of the CNS at the time of the trauma may result in permanent neuronal changes that have a negative effect on learning, habituation, and stimulus discrimination. These neuronal changes would not depend on actual exposure to reminders of the trauma for expression. The abnormal startle response characteristic of PTSD (10) exemplifies such neuronal changes.

Despite the fact that an abnormal acoustic startle response (ASR) has been seen as a cardinal feature of the trauma response for over half a century, systematic explorations of the ASR in PTSD have just begun. The ASR consists of a characteristic sequence of muscular and autonomic responses elicited by sudden and intense stimuli (30,31). The neuronal pathways involved consist of only a small number of mediating synapses between the receptor and effector and a large projection to brain areas responsible for CNS activation and stimulus evaluation (31). The ASR is mediated by excitatory amino acids such as glutamate and aspartate and is modulated by a variety of neurotransmitters and second messengers at both the spinal and supraspinal level (32). Habituation of the ASR in normals occurs after 3 to 5 presentations (30).

Several studies have demonstrated abnormalities in habituation to the ASR in PTSD (33,34,35,36). Shalev et al (33) found a failure to habituate both to CNS and ANS-mediated responses to ASR in 93% of the PTSD group, compared with 22% of the control subjects. Interestingly, people who previously met criteria for PTSD, but no longer do so now, continue to show failure of habituation of the ASR (van der Kolk et al, unpublished data; Pitman et al, unpublished data), which raises the question whether abnormal habituation to acoustic startle is a marker of, or a vulnerability factor for developing PTSD.

The failure to habituate to acoustic startle suggests that traumatized people have difficulty evaluating sensory stimuli, and mobilizing appropriate levels of physiological arousal(30). Thus, the inability of people with PTSD to properly integrate memories of the trauma and, instead, to get mired in a continuous reliving of the past, is mirrored physiologically in the misinterpretation of innocuous stimuli, such as the ASR, as potential threats.
The Hormonal Stress Response & the Psychobiology of PTSD

Post Traumatic Stress Disorder develops following exposure to events that are intensely distressing. Intense stress is accompanied by the release of endogenous, stress-responsive neurohormones, such as cortisol, epinephrine and norepinephrine (NE), vasopressin, oxytocin and endogenous opioids. These stress hormones help the organism mobilize the required energy to deal with the stress, ranging from increased glucose release to enhanced immune function. In a well-functioning organism, stress produces rapid and pronounced hormonal responses. However, chronic and persistent stress inhibits the effectiveness of the stress response and induces desensitization (37).

Much still remains to be learned about the specific roles of the different neurohormones in the stress response. NE is secreted by the Locus Coeruleus(LC) and distributed through much of the CNS, particularly the neocortex and the limbic system, where it plays a role in memory consolidation and helps initiate fight/ flight behaviors. Adrenocorticotropin (ACTH) is released from the anterior pituitary, and activates a cascade of reactions, eventuating in release of glucocorticoids from the adrenals. The precise interrelation between Hypothalamic-Pituitary-Adrenal (HPA) Axis hormones and the catecholamines in the stress response is not entirely clear, but it is known that stressors that activate NE neurons also increase CRF concentrations in the LC (38), while intracerebral ventricular infusion of CRF increases NE in the forebrain (39). Glucocorticoids and catecholamines may modulate each other's effects: in acute stress, cortisol helps regulate stress hormone release via a negative feedback loop to the hippocampus, hypothalamus and pituitary (40) and there is evidence that corticosteroids normalize catecholamine-induced arousal in limbic midbrain structures in response to stress (41). Thus, the simultaneous activation of corticosteroids and catecholamines could stimulate active coping behaviors, while increased arousal in the presence of low glucocorticoid levels may promote undifferentiated fight or flight reactions (42).

While acute stress activates the HPA axis and increases glucocorticoid levels, organisms adapt to chronic stress by activating a negative feedback loop that results in 1) decreased resting glucocorticoid levels in chronically stressed organisms, (43), 2) decreased glucocorticoid secretion in response to subsequent stress (42), and 3) increased concentration of glucocorticoid receptors in the hippocampus (44). Yehuda has suggested that increased concentration of glucocorticoid receptors could facilitate a stronger glucocorticoid negative feedback, resulting in a more sensitive HPA axis and a faster recovery from acute stress (45).

Chronic exposure to stress affects both acute and chronic adaptation: it permanently alters how an organism deals with its environment on a day-to-day basis, and it interferes with how it copes with subsequent acute stress (45).
Neuroendocrine Abnormalities in PTSD

Since there is an extensive animal literature on the effects of inescapable stress on the biological stress response of other species, such as monkeys and rats, much of the biological research on people with PTSD has focussed on testing the applicability of those research findings to people with PTSD (46,47). People with PTSD, like chronically and inescapbly shocked animals, seem to suffer from a persistent activation of the biological stress response upon exposure to stimuli reminiscent of the trauma.

1) Catecholamines. Neuroendocrine studies of Vietnam veterans with PTSD have found good evidence for chronically increased sympathetic nervous system activity in PTSD. One study (48) found elevated 24h excretions of urinary NE and epinephrine in PTSD combat veterans compared with patients with other psychiatric diagnoses. While Pitman & Orr (49) did not replicate these findings in 20 veterans and 15 combat controls, the mean urinary NE excretion values in their combat controls (58.0 ug/day) were substantially higher than those previously reported in normal populations. The expected compensatory downregulation of adrenergic receptors in response to increased levels of norepinephrine was confirmed by a study that found decreased platelet alpha-2 adrenergic receptors in combat veterans with PTSD, compared with normal controls (50). Another study also found an abnormally low alpha-2 adrenergic receptor-mediated adenylate cyclase signal transduction (51). In a recent study Southwick et al (52) used yohimbine injections (0.4 mg/kg), which activate noradrenergic neurons by blocking the alpha-2 auto- receptor, to study noradrenergic neuronal dysregulation in Vietnam veterans with PTSD. Yohimbine precipitated panic attacks in 70% of subjects and flashbacks in 40%. Subjects responded with larger increases in plasma MHPG than controls. Yohimbine precipitated significant increases in all PTSD symptoms.

2) Corticosteroids. Two studies have shown that veterans with PTSD have low urinary cortisol excretion, even when they have comorbid major depressive disorder (42,53). One study failed to replicate this finding (49). In a series of studies, Yehuda et al (42,54) found increased numbers of lymphocyte glucocorticoid receptors in Vietnam veterans with PTSD. Interestingly, the number of glucocorticoid receptors was proportional to the severity of PTSD symptoms. Yehuda (54) also has reported the results of an unpublished study by Heidi Resnick, in which acute cortisol response to trauma was studied from blood samples from 20 acute rape victims. Three months later, a prior trauma history was taken, and the subjects were evaluated for the presence of PTSD. Victims with a prior history of sexual abuse were significantly more likely to have developed PTSD three months following the rape than rape victims who did not develop PTSD. Cortisol levels shortly after the rape were correlated with histories of prior assaults: the mean initial cortisol level of individuals with a prior assault history was 15 ug/dl compared to 30 ug/dl in individuals without. These findings can be interpreted to mean either that prior exposure to traumatic events result in a blunted cortisol response to subsequent trauma, or in a quicker return of cortisol to baseline following stress. The fact that Yehuda et al (45) also found subjects with PTSD to be hyperresponsive to low doses of dexamethasone argues for an enhanced sensitivity of the HPA feedback in traumatized patients.

3) Serotonin. While the role of serotonin in PTSD has not been systematically investigated, both the fact that inescapably shocked animals develop decreased CNS serotonin levels (55), and that serotonin re-uptake blockers are effective pharmacological agents in the treatment of PTSD, justify a brief consideration of the potential role of this neurotransmitter in PTSD. Decreased serotonin in humans has repeatedly been correlated with impulsivity and aggression (56,57,58). The literature tends to readily assume that these relationships are based on genetic traits. However, studies of impulsive, aggressive and suicidal patients seem to find at least as robust an association between those behaviors and histories of childhood trauma (e.g. 59,60,61). It is likely that both temperament and experience affect relative CNS serotonin levels (12).

Low serotonin in animals is also related to an inability to modulate arousal, as exemplified by an exaggerated startle (62,63), and increased arousal in response to novel stimuli, handling, or pain (63). The behavioral effects of serotonin depletion on animals is characterized by hyperirritability, hyperexitability, and hypersensitivity, and an "...exaggerated emotional arousal and/or aggressive display, to relatively mild stimuli" (63). These behaviors bear a striking resemblance to the phenomenology of PTSD in humans. Furthermore, serotonin re-uptake inhibitors have been found to be the most effective pharmacological treatment of both obsessive thinking in people with OCD (64), and of involuntary preoccupation with traumatic memories in people with PTSD (65,66). It is likely that serotonin plays a role in the capacity to monitor the environment flexibly and to respond with behaviors that are situation-appropriate, rather than reacting to internal stimuli that are irrelevant to current demands.

4). Endogenous opioids. Stress induced analgesia (SIA) has been described in experimental animals following a variety of inescapable stressors such as electric shock, fighting, starvation and cold water swim (67). In severely stressed animals, opiate withdrawal symptoms can be produced both by termination of the stressful stimulus or by naloxone injections. Stimulated by the findings that fear activates the secretion of endogenous opioid peptides, and that SIA can become conditioned to subsequent stressors and to previously neutral events associated with the noxious stimulus, we tested the hypothesis that in people with PTSD, re-exposure to a stimulus resembling the original trauma will cause an endogenous opioid response that can be indirectly measured as naloxone reversible analgesia (68,69). We found that two decades after the original trauma, people with PTSD developed opioid-mediated analgesia in response to a stimulus resembling the traumatic stressor, which we correlated with a secretion of endogenous opioids equivalent to 8 mg of morphine. Self-reports of emotional responses suggested that endogenous opioids were responsible for a relative blunting of the emotional response to the traumatic stimulus.
Endogenous Opiates & Stress Induced Analgesia: Possible Implications for Affective Function

When young animals are isolated, and older ones attacked, they respond initially with aggression (hyperarousal- fight- protest), and, if that does not produce the required results, with withdrawal (numbing-flight-despair). Fear-induced attack or protest patterns in the young serve to attract protection, and in mature animals to prevent or counteract the predator's activity. During external attacks pain-inhibition is a useful defensive capacity, because attention to pain would interfere with effective defense: grooming or licking wounds may attract opponents and stimulate further attack (70). Thus defensive and pain-motivated behaviors are mutually inhibitory. Stress-induced analgesia protects organisms against feeling pain while engaged in defensive activities. As early as 1946, Beecher (71), after observing that 75% of severely wounded soldiers on the Italian front did not request morphine, speculated that "strong emotions can block pain". Today, we can reasonably assume that this is due to the release of endogenous opioids(68,69).

Endogenous opioids, which inhibit pain and reduce panic, are secreted after prolonged exposure to severe stress. Siegfried et al (70) have observed that memory is impaired in animals when they can no longer actively influence the outcome of a threatening situation. They showed that both the freeze response and panic interfere with effective memory processing: excessive endogenous opioids and NE both interfere with the storage of experience in explicit memory. Freeze/numbing responses may serve the function of allowing organisms to not "consciously experience" or not to remember situations of overwhelming stress (and which thus will also keep them from learning from experience). We have proposed that the dissociative reactions in people in response to trauma may be analogous to this complex of behaviors that occur in animals after prolonged exposure to severe uncontrollable stress (68).
Developmental Level Affects the Psychobiological Effects of Trauma

While most studies on PTSD have been done on adults, particularly on war veterans, in recent years a small prospective literature is emerging that documents the differential effects of trauma at various age levels. Anxiety disorders, chronic hyperarousal, and behavioral disturbances have been regularly described in traumatized children (e.g.72,73,74). In addition to the reactions to discrete, one time, traumatic incidents documented in these studies, intrafamilial abuse is increasingly recognized to produce complex post-traumatic syndromes (75), which involve chronic affect dysregulation, destructive behavior against self and others, learning disablities, dissociative problems, somatization, and distortions in concepts about self and others (76,77). The Field Trials for DSM IV showed that these this conglomeration of symptoms tended to occur together and that the severity of this syndrome was proportional to the age of onset of the trauma and its duration (78).

While current research on traumatized children is outside the scope of this review, it is important to recognize that a range of neurobiological abnormalities are beginning to be identified in this population. Frank Putnam's prospective, but as yet unpublished, studies (personal communications, 1991,1992,1993) are showing major neuroendocrine disturbances in sexually abused girls compared with normals. Research on the psychobiology of childhood trauma can be profitably informed by the vast literature on the psychobiological effects of trauma and deprivation in non-human primates (12,79).
Trauma & Memory: The Flexibility of Memory & the Engraving of Trauma

One hundred years ago, Pierre Janet (1) suggested that the most fundamental of mental activities is the storage and categorization of incoming sensations into memory, and the retrieval of those memories under appropriate circumstances. He, like contemporary memory researchers, understood that what is now called semantic, or declarative, memory is an active and constructive process and that remembering depends on existing mental schemata (3,80): once an event or a particular bit of information is integrated into existing mental schemes, it will no longer be accessible as a separate, immutable entity, but be distorted both by prior experience, and by the emotional state at the time of recall(3). PTSD, by definition, is accompanied by memory disturbances, consisting of both hypermnesias and amnesias (9,10). Research into the nature of traumatic memories (3) indicates that trauma interferes with delarative memory, i.e. conscious recall of experience, but does not inhibit implicit, or non-declarative memory, the memory system that controls conditioned emotional responses, skills and habits, and sensorimotor sensations related to experience. There now is enough information available about the biology of memory storage and retrieval to start building coherent hypotheses regarding the underlying psychobiological processes involved in these memory disturbances (3,16,17,25).

In the beginning of this century Janet already noted that: "certain happenings ... leave indelible and distressing memories-- memories to which the sufferer continually returns, and by which he is tormented by day and by night" (81). Clinicians and researchers dealing with traumatized patients have repeatedly made the observation that the sensory experiences and visual images related to the trauma seem not to fade over time, and appear to be less subject to distortion than ordinary experiences (1,49,82). When people are traumatized, they are said to experience "speechless terror": the emotional impact of the event may interfere with the capacity to capture the experience in words or symbols. Piaget (83) thought that under such circumstances, failure of semantic memory leads to the organization of memory on a somatosensory or iconic level (such as somatic sensations, behavioral enactments, nightmares and flashbacks). He pointed out: "It is precisely because there is no immediate accommodation that there is complete dissociation of the inner activity from the external world. As the external world is solely represented by images, it is assimilated without resistance (i.e. unattached to other memories) to the unconscious ego".
Traumatic memories are state dependent.

Research has shown that, under ordinary conditions, many traumatized people, including rape victims (84), battered women (85) and abused children (86) have a fairly good psychosocial adjustment. However, they do not respond to stress the way other people do. Under pressure, they may feel, or act as if they were traumatized all over again. Thus, high states of arousal seem to selectively promote retrieval of traumatic memories, sensory information, or behaviors associated with prior traumatic experiences (9,10). The tendency of traumatized organisms to revert to irrelevant emergency behaviors in response to minor stress has been well documented in animals, as well. Studies at the Wisconsin primate laboratory have shown that rhesus monkeys with histories of severe early maternal deprivation display marked withdrawal or aggression in response to emotional or physical stimuli (such as exposure to loud noises, or the administration of amphetamines), even after a long period of good social adjustment (87). In experiments with mice, Mitchell and his colleagues (88) found that the relative degree of arousal interacts with prior exposure to high stress to determine how an animal will react to novel stimuli. In a state of low arousal, animals tend to be curious and seek novelty. During high arousal, they are frightened, avoid novelty, and perseverate in familiar behavior, regardless of the outcome. Under ordinary circumstances, an animal will choose the most pleasant of two alternatives. When hyperaroused, it will seek whatever is familiar, regardless of the intrinsic rewards. Thus, animals who have been locked in a box in which they were exposed to electric shocks and then released return to those boxes when they are subsequently stressed. Mitchell concluded that this perseveration is nonassociative, i.e. uncoupled from the usual reward systems.

In people, analogous phenomena have been documented: memories (somatic or symbolic) related to the trauma are elicited by heightened arousal (89). Information acquired in an aroused, or otherwise altered state of mind is retrieved more readily when people are brought back to that particular state of mind (90,91). State dependent memory retrieval may also be involved in dissociative phenomena in which traumatized persons may be wholly or partially amnestic for memories or behaviors enacted while in altered states of mind (2,3,92).

Contemporary biological researchers have shown that medications that stimulate autonomic arousal may precipitate visual images and affect states associated with prior traumatic experiences in people with PTSD, but not in controls. In patients with PTSD the injection of drugs such as lactate (93) and yohimbine (52) tends to precipitate panic attacks, flashbacks (exact reliving experiences) of earlier trauma, or both. In our own laboratory, approximately 20% of PTSD subjects responded with a flashback of a traumatic experience when they were presented with acoustic startle stimuli.
Trauma, neurohormones and memory consolidation.

When people are under severe stress, they secrete endogenous stress hormones that affect the strength of memory consolidation. Based on animal models it has been widely assumed (3,46,94) that massive secretion of neurohormones at the time of the trauma plays a role in the long term potentiation (LTP) (and thus, the over- consolidation) of traumatic memories. Mammals seem equipped with memory storage mechanisms that ordinarily modulate the strength of memory consolidation according to the strength of the accompanying hormonal stimulation (95,96). This capacity helps the organism evaluate the importance of subsequent sensory input according to the relative strength of associated memory traces. This phenomenon appears to be largely mediated by NE input to the amygdala (97,98, figure 2). In traumatized organisms, the capacity to access relevant memories appears to have gone awry: they become overconditioned to access memory traces of the trauma and to "remember" the trauma whenever aroused. While norepinephrine (NE) seems to be the principal hormone involved in producing LTP, other neurohormones secreted under particular stressful circumstances, such as endorphins and oxytocin, actually inhibit memory consolidation (99).

The role of NE in memory consolidation has been shown to have an inverted U-shaped function (95,96): both very low and very high levels of CNS NE activity interfere with memory storage. Excessive NE release at the time of the trauma, as well as the release of other neurohormones, such as endogenous opioids, oxytocin and vasopressin, are likely to play a role in creating the hypermnesias and the amnesias that are a quintessential part of PTSD (9,10). It is of interest that childbirth, which can be extraordinarily stressful, almost never seems to result in post traumatic problems (100). Oxytocin may play a protective role that prevents the overconsolidation of memories surrounding childbirth.

Physiological arousal in general can trigger trauma-related memories, while, conversely, trauma-related memories precipitate generalized physiological arousal. It is likely that the frequent re-living of a traumatic event in flashbacks or nightmares cause a re-release of stress hormones which further kindle the strength of the memory trace (46). Such a positive feedback loop could cause subclinical PTSD to escalate into clinical PTSD (16), in which the strength of the memories appear so deeply engraved that Pitman and Orr (17) have called it "the Black Hole" in the mental life of the PTSD patient, that attracts all associations to it, and saps current life of its significance.
Memory, Trauma & the Limbic System

The limbic system is thought to be the part of the CNS that maintains and guides the emotions and behavior necessary for self-preservation and survival of the species (101), and that is critically involved in the storage and retrieval of memory. During both waking and sleeping states signals from the sensory organs continuously travel to the thalamus whence they are distributed to the cortex (setting up a "stream of thought"), to the basal ganglia (setting up a "stream of movement") and to the limbic system where they set up a "stream of emotions"(102), that determine the emotional significance of the sensory input. It appears that most processing of sensory input occurs outside of conscious awareness, and only novel, significant or threatening information is selectively passed on to the neocortex for further attention. Since people with PTSD appear to over-interpret sensory input as a recurrence of past trauma and since recent studies have suggested limbic system abnormalities in brain imaging studies of traumatized patients (103,104), a review of the psychobiology of trauma would be incomplete without considering the role of the limbic system in PTSD (also see 105). Two particular areas of the limbic system have been implicated in the processing of emotionally charged memories: the amygdala and the hippocampus (Table 2).

The amygdala. Of all areas in the CNS, the amygdala is most clearly implicated in the evaluation of the emotional meaning of incoming stimuli (106). Several investigators have proposed that the amygdala assigns free-floating feelings of significance to sensory input, which the neocortex then further elaborates and imbues with personal meaning (101,106,107,108). Moreover, it is thought to integrate internal representations of the external world in the form of memory images with emotional experiences associated with those memories (80). After assigning meaning to sensory information, the amygdala guides emotional behavior by projections to the hypothalamus, hippocampus and basal forebrain (106,107,109).

The septo-hippocampal system, which anatomically is adjacent to the amygdala, is thought to record in memory the spatial and temporal dimensions of experience and to play an important role in the categorization and storage of incoming stimuli in memory. Proper functioning of the hippocampus is necessary for explicit or declarative memory (109). The hippocampus is thought to be involved in the evaluation of spatially and temporally unrelated events, comparing them with previously stored information and determining whether and how they are associated with each other, with reward, punishment, novelty or non-reward (107,110). The hippocampus is also implicated in playing a role in the inhibition of exploratory behavior and in obsessional thinking, while hippocampal damage is associated with hyper-responsiveness to environmental stimuli (111,112).

The slow maturation of the hippocampus, which is not fully myelinated till after the third or fourth year of life, is seen as the cause of infantile amnesia (113,114). In contrast, it is thought that the memory system that subserves the affective quality of experience (roughly speaking procedural, or "taxon" memory) matures earlier and is less subject to disruption by stress (112).

As the CNS matures, memory storage shifts from primarily sensorimotor (motoric action) and perceptual representations (iconic), to symbolic and linguistic modes of organization of mental experience (83). With maturation, there is an increasing ability to categorize experience, and link it with existing mental schemes. However, even as the organism matures, this capacity, and with it, the hippocampal localization system, remains vulnerable to disruption (45,107,110,115,116). A variety of external and internal stimuli, such as stress induced corticosterone production (117), decreases hippocampal activity. However, even when stress interferes with hippocampally mediated memory storage and categorization, it is likely that some mental representation of the experience is laid down by means of a system that records affective experience, but that has no capacity for symbolic processing and placement in space and time (figure 2).

Decreased hippocampal functioning causes behavioral disinhibition, possibly by stimulating incoming stimuli to be interpreted in the direction of "emergency" (fight/flight) responses. The neurotransmitter serotonin plays a crucial role in the capacity of the septo-hippocampal system to activate inhibitory pathways that prevent the initiation of emergency responses until it is clear that they will be of use (110). This observation made us very interested in a possible role for serotonergic agents in the treatment of PTSD.
"Emotional memories are forever"

In animals, high level stimulation of the amygdala interferes with hippocampal functioning (107, 109). This implies that intense affect may inhibit proper evaluation and categorization of experience. In mature animals one-time intense stimulation of the amygdala will produce lasting changes in neuronal excitability and enduring behavioral changes in the direction of either fight or flight (118). In kindling experiments with animals, Adamec et al (119) have shown that, following growth in amplitude of amygdala and hippocampal seizure activity, permanent changes in limbic physiology cause a lasting changes in defensiveness and in predatory aggression. Pre-existing "personality" played a significant role in the behavioral effects of amygdala stimulation in cats: animals that are temperamentally insensitive to threat and prone to attack tend become more aggressive, while in highly defensive animals different pathways were activated, increasing behavioral inhibition (119).

In a series of experiments, LeDoux has utilized repeated electrical stimulation of the amygdala to produce conditioned fear responses. He found that cortical lesions prevent their extinction. This led him to conclude that, once formed, the subcortical traces of the conditioned fear response are indelible, and that "emotional memory may be forever" (118). In 1987, Lawrence Kolb (29) postulated that patients with PTSD suffer from impaired cortical control over subcortical areas responsible for learning, habituation, and stimulus discrimination. The concept of indelible subcortical emotional responses, held in check to varying degrees by cortical and septo-hippocampal activity, has led to the speculation that delayed onset PTSD may be the expression of subcortically mediated emotional responses that escape cortical, and possibly hippocampal, inhibitory control (3,16,94,120,121).

Decreased inhibitory control may occur under a variety of circumstances: under the influence of drugs and alcohol, during sleep (as nightmares), with aging, and after exposure to strong reminders of the traumatic past. It is conceivable that traumatic memories then could emerge, not in the distorted fashion of ordinary recall, but as affect states, somatic sensations or as visual images (nightmares [81] or flashbacks [52]) that are timeless and unmodified by further experience.
Psychopharmacological Treatment

The goal of treatment of PTSD is to help people live in the present, without feeling or behaving according to irrelevant demands belonging to the past. Psychologically, this means that traumatic experiences need to be located in time and place and distinguished from current reality. However, hyperarousal, intrusive reliving, numbing and dissociation get in the way of separating current reality from past trauma. Hence, medications that affect these PTSD symptoms are often essential for patients to begin to achieve a sense of safety and perspective from which to approach their tasks. While numerous articles have been written about the drug treatment of PTSD, to date, only 134 people with PTSD have been enrolledin published double blind studies. Most of these have been Vietnamcombat veterans. Unfortunately, up until recently, only medications which seem to be of limited therapeutic usefulness have beenthesubject of adequate scientific scrutiny. While the only published double blind studies of medications in the treatment of PTSDhave been tricyclic antidepressants and MAO Inhibitors (122,123,124), it is sometimes assumed that they therefore also are themosteffective. Three double-blind trials of tricyclic antidepressants have been published (122,124,125), two of which demonstrated modest improvement in PTSD symptoms. While positive resultshave been claimed for numerous other medications in case reportsand open studies, at the present time there are no data aboutwhich patient and which PTSD symptom will predictably respond toanyof them. Success has been claimed for just about every class ofpsychoactive medication, including benzodiazepines (127), tricyclic antidepressants (122,125), monamine oxidase inhibitors (122,129) lithium carbonate (127), beta adrenergic blockers and clonidine (130), carbamezapine (131) and antipsychotic agents. The accumulated clinical experience seems to indicate that understanding thebasic neurobiology of arousal and appraisal is the most useful guideinselecting medications for people with PTSD (124,125). Autonomic arousal can be reduced at different levels in the CNS: throughinhibition of locus coeruleus noradrenergic activity with clonidine and the beta adrenergic blockers (130,132), or by increasing the inhibitory effect of the gaba-ergic system with gaba- ergicagonists (the benzodiazepines). During the past two years a numberof case reports and open clinical trials of fluoxetine were followedby our double blind study of 64 PTSD subjects with fluoxetine (65). Unlike the tricyclic antidepressants, which were effective on either the intrusive (imipramine) or numbing (amitryptiline) symptoms of PTSD, fluoxetine proved to be effective forthewhole spectrum of PTSD symptoms. It also acted more rapidly thanthetricyclics. The fact that fluoxetine has proven to be such aneffective treatment for PTSD supports a larger role of the serotonergic system in PTSD (66). Rorschach tests adminstered by blindscorers revealed that subjects on fluoxetine became able to takedistance from the emotional impact of incoming stimuli and to becomeable to utilize cognition to harness the emotional responses tounstructured visual stimuli (van der Kolk et al, unpublished).

While the subjects improved clinically, their startle habituation got worse (van der Kolk et al, unpublished). The 5-HT1a agonist buspirone shows some promise in facilitating habituation (133) and thus may play a useful adjunctive role in the pharmaco- therapy of PTSD. Even newer research has suggested abnormalities of the N-methyl-D-aspartate (NMDA) receptor and of glutamate in PTSD (134), opening up potential new avenues for the psychopharmacological treatment of PTSD.

Labels: , , , , ,

Monday, November 19, 2007

Nutrient defieciency and aggression

Melvyn R. Werbach, M.D. Journal Of Orthomolecular Medicine Vol. 7, No. 1, 1995 Introduction The aggressive behavioral syndrome is marked by restlessness, irritability, impulsivity and a proneness to violence. Diagnostically, it overlaps the DSM III-R diagnoses of Attention-deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant Disorder and Antisocial Personality Disorder. When the syndrome is attributed to organic factors, it would frequently be classified as an Organic Personality Syndrome.1 Constitutional factors, including genetics and the effects of disease and physical trauma, are known to play a major role in determining proneness to overaggressive behaviors. The importance of psychological factors is also well known. By contrast, the contribution of nutritional factors to such behaviors is often unrecognized, and therefore not properly addressed. Nutritional factors are neglected for a number of reasons. Much of the literature on nutritional treatments has yet to evolve beyond the early stages of scientific investigation. Physicians learn so little about nutritional medicine during their training that they feel too uninformed to include it in their practices. Sub-optimal nutrition is generally believed to be rare in industrialized societies - even though up to 50% of the population may fail to ingest the Recommended Dietary Allowance for one or more vitamins or minerals.2 In regard to behavioral syndromes, nutritional factors are neglected, in part, because marginal nutritional deficiencies are not believed to affect behavior despite growing evidence to suggest that that belief may be false. (For example, subtle neuropsychological impairment has been documented by EEG recordings of older subjects in association with any of a number of marginal nutritional deficiencies. 3 Literature Review 1. Vitamins Deficiencies of several vitamins are known to be associated with irritability. These include niacin,4 pantothenic acid,5 thiamine,6 vitamin B67 and vitamin C.8 In industrialized societies, the classic vitamin deficiency diseases are rare, although marginal vitamin nutriture due either to inadequate intake or to vitamin dependency appears to be fairly common. Moreover, under laboratory conditions, adverse behavioral changes precede specific clinical findings in a number of vitamin deficiencies.9 It is not known how frequently overaggressive behaviors are a manifestation of marginal vitamin nutriture. While little has been published to prove a relationship between the aggressive behavioral syndrome in humans and marginal vitamin nutriture, Lonsdale and Shamberger, writing in The American Journal of Clinical Nutrition, reported on twenty people eating "junk food" diets who were found to have biochemical evidence of marginal thiamine deficiency. Their subjects, and particularly the adolescents, were impulsive, highly irritable, aggressive and sensitive to criticism. Following thiamine supplementation, their behavior improved concurrent with laboratory evidence of improved thiamine nutriture, suggesting that marginal thiamine deficiency may have contributed to their aggressive behavioral syndrome.6 Hopefully, well-controlled studies will eventually provide a clearer picture of the importance of marginal vitamin deficiencies in promoting overaggressive behaviors. 2. Minerals Note: for the sake of completeness, minerals which do not function as nutrients are included in this review. Iron The most common nutritional deficiency in industrialized societies, 10% of American males and 3% of American females are overtly iron-deficient (ferritin less than 10 mg/mL.10 A deficiency of iron is known to interfere with proper brain function. Dopamine is a major neurotransmitter in the brain, iron is highly concentrated in the dopamine pathways, and animal studies have shown that iron deficiency may cause learning deficits and consequent behavioral impairment by diminishing dopamine neurotransmission.11 Iron is also needed as a co-factor for the enzymes which metabolize not only dopamine, but also serotonin and norepinephrine, which also have a potent influence on behavior. Evidence is now emerging that iron deficiency may be an important contributor to the aggressive behavioral syndrome. Among adolescent males, iron deficiency has been shown to be directly associated with aggressive behavior (Conduct Disorder).12 Moreover, in a population of incarcerated adolescents, the prevalence of iron deficiency was nearly twice that found in their non-incarcerated peers.13 Lithium There is considerable evidence that pharmacologic doses of lithium, which has no known essential function, can reduce abnormal aggressive behaviors including self-mutilation.14 Lithium has been used successfully with treatment-resistant hospitalized children with diagnoses of Conduct Disorder, Aggressive Type,15 as well as with brain-injured16 and mentally retarded17 patients with aggressive, combative or self-destructive behavior. While often effective, lithium at pharmacologic doses (generally 900,000 micrograms or more daily) has serious limitations. It suffers from many potential side effects, some of which are common. Because it becomes toxic at a serum level which is not much higher than the therapeutic range, serum lithium levels must be tested periodically. For these reasons, patients must be under medical supervision so long as they are taking the drug. It is possible that lithium may exert a powerful effect on overaggressive behaviors at far lower levels of intake. Using data from 27 Texas counties, Schrauzer and Shrestha found that the incidences of suicide, homicide and rape were significantly higher in counties whose drinking water supplies contained little or no lithium than in counties with higher water lithium levels, even after correcting for population density. Corresponding associations with the incidences of robbery, burglary and theft were also significant, as were associations with the incidences of arrests for possession of opium, cocaine and their derivatives. Only the incidences of arrests for possession of marijuana, driving under the influence of alcohol, and drunkenness failed to correlate with the water lithium level.18 While the effect of low-dose lithium supplementation on overaggressive behaviors has not been reported, results of an uncontrolled study suggest that low-dose lithium derived from vegetable concentrates may have a powerful effect on mental state and behavior. Thirteen depressed patients with bipolar disorder were treated with natural lithium derived from vegetable concentrates. All improved in about ten days and there were no adverse effects. After six weeks, they were taken off of lithium and all regressed to their former depressed state within three days. Two days after lithium was resupplied, their depressions lifted again.19 If we assume that a person consumes about one liter of water daily from municipal supplies, it is striking that the level of lithium provided from the vegetable concentrates approximates that consumed by residents of the Texas counties with higher lithium levels: "Natural" lithium dosage - 150 micrograms daily; Lithium level of drinking water in the Texas counties with higher levels18 - 70-170 micrograms per liter. Magnesium Rodent studies suggest that magnesium has a complex relationship with aggressive behaviors. Magnesium deficiency reduces offensive aggressive behavior but increases defensive aggressive behavior.20 Lower levels of magnesium supplementation increase the number of attacks on intruders while higher levels have the opposite effect.21 In humans, magnesium deficiency, which enhances catecholamine secretion and sensitivity to stress, may promote aggressive behavior. Increased catecholamines, in turn, induce intracellular magnesium losses and, eventually, increased urinary losses of magnesium.22 It has been suggested that the Type A behavior pattern - which is associated with chronic stress and aggressive behavior - may both cause and be caused by magnesium deficiency.22 Also, suicide attempts, which are violently aggressive acts against the self, have been correlated with lowered magnesium levels in the cerebrospinal fluid.23 Manganese Manganese is an essential trace mineral. Massive overexposure produces "manganese madness" which may initially be marked by violence, criminal acts and a state of mental excitement; later, neurological impairment slowly develops, with signs and symptoms which resemble Parkinson's disease. The behavioral effects of marginal levels of manganese toxicity have not been described. Recently, Gottschalk and his associates consistently found elevated hair manganese in a population of violent male offenders, suggesting that marginal manganese toxicity may be associated with violent criminal behavior. Compared to the hair manganese levels which they found, people exposed to levels of manganese pollution which are known to be toxic possess hair values that are two to six times higher.24 Elevated hair manganese levels have also been reported in hyperkinetic children,25, 26 and men with a history of childhood hyperactivity have an increased rate of antisocial and drug use disorders.27 In rats, chronic manganese exposure initially produces hyperactivity with an increased tendency to fight.28 While any hypothesis concerning the behavioral effects of marginal manganese toxicity in humans is highly speculative, these findings suggest that marginal manganese toxicity may promote overaggressive behaviors in adults. Heavy Metals Brain damage due to toxic metal exposure may promote aggressive, antisocial and violent behaviors. Lead exposure is known to cause learning and behavioral problems, problems which are found in a substantial portion of juvenile delinquents. The strongest evidence to date that lead exposure increases the frequency of aggressive behaviors comes from the Edinburgh Lead Study which included over 500 children between the ages of 6 and 9. After taking 30 possible confounding variables into account, the investigators still found a significant relationship between the log of blood lead levels and teachers' ratings of the childrens' behavior on an "aggressive/antisocial" scale and on a "hyperactive" scale, but not on a "neurotic" scale. As in other studies on the relationship between lead exposure and brain damage, a dose-response relationship was found between blood lead and behavior ratings, with no evidence of a threshold.29 Pihl and associates have addressed the relationship of lead exposure and violent behavior in adults. Hair lead levels from 19 violent criminals were found to be elevated as compared with those of 10 nonviolent criminals.30 This study was repeated 8 years later by the same research team with essentially the same results. However, their results were contradicted by those of the recent Gottschalk study on hair manganese levels; in that study, no significant differences were found between hair lead levels of 104 violent criminals, prison guards and local townspeople.24 As with lead, studies comparing hair cadmium levels of violent male offenders to matched controls have had conflicting results. One study published in the Journal of Learning Disabilities looked at hair cadmium levels of 40 apparently normal young men entering US Navy recruit training and found a highly significant relationship between hair cadmium levels and the number of demerits each recruit had received. Moreover, the three recruits who had the highest cadmium levels all displayed serious behavior difficulties during training.31 Exposure to aluminum may also contribute to overaggressive behaviors. Hair aluminum levels of a group of 22 juvenile offenders,32 as well as of another group of 10 severely delinquent, psychotic or prepsychotic adolescent boys,33 were elevated. However, both studies compared aluminum levels to laboratory norms rather than to matched controls; thus other differences between the groups could account for the findings. 3. Amino Acids Tryptophan Serotonin, a major neurotransmitter, has been found to play an important role in modulating aggressive behavior. Impulsive, violent and suicidal behaviors have repeatedly been shown to be associated with a reduction in serotonergic activity in the central nervous system.34 Tryptophan, an essential amino acid, is the dietary precursor to serotonin, and several lines of evidence have suggested that the amount of tryptophan in the diet relates closely to aggressive behavior. For example, rats given a diet almost lacking in tryptophan develop aggressive behavior towards mice.35 Tryptophan must compete with other large neutral amino acids to cross the blood-brain barrier; therefore the ratio of the amount of tryptophan to the amount of competing amino acids (the tryptophan ratio) may provide a rough indication of the availability of tryptophan in the brain for conversion into serotonin. Kitahara has calculated the dietary tryptophan ratio for 18 European countries to attempt to relate it to homicide rates. While initially no correlation was found between low tryptophan ratios and homicide, once social and cultural differences were controlled for, low tryptophan ratios were found to be associated with high homicide rates.36 A more direct method of examining the relationship between the tryptophan ratio and aggression is by measuring the actual ratio in the blood plasma. When a group of depressed alcoholics was evaluated in this manner, those with a history of aggression, including suicide attempts, also had the lowest tryptophan ratios.37 If a low ratio of tryptophan to competing amino acids is associated with aggressive behavior, will tryptophan supplementation reduce that behavior? Dietary tryptophan was manipulated in social groups of vervet monkeys by providing them with amino acid mixtures that were tryptophan-free, nutritionally balanced, or excessively high in tryptophan. These mixtures were shown to have a marked effect on plasma tryptophan levels. During spontaneous activity, the only effect of the different mixtures was increased aggression in the males on the tryptophan-free mixture. During competition for food, however, while the tryptophan-free mixture continued to increase male aggression, the high-tryptophan mixture reduced aggression in both males and females.38 These data suggest that tryptophan supplementation may be most effective in reducing aggression during times of stress. When hospitalized male schizophrenics were given tryptophan, only those patients with high levels of hostility and a high lifetime frequency of aggressive incidents benefited; these patients showed a lessening of hostility and depression, a reduction in ward incidents and improvement on a standardized psychiatric rating scale.39 In another study of twenty aggressive patients, 6 g of tryptophan daily for one month failed to reduce the number of violent incidents, although it significantly reduced the need for potent medications to control violent or agitated behavior.40 The rate of firing of serotonergic neurons in the brain increases as the level of behavioral arousal increases; thus increased serotonin levels would be more likely to influence brain function at higher levels of arousal. Indeed, this fact probably explains why the vervet monkeys only responded to tryptophan supplementation when they were put under competitive stress. It also may explain why altered tryptophan levels failed to affect aggression in a study of normal human males, while overaroused, hostile and aggressive psychiatric patients responded well. In the conversion of tryptophan to serotonin, the intermediate step is its conversion to 5-hydroxytryptophan. Surprisingly, supplementation with 5-hydroxytryptophan may increase aggressive behavior, apparently because, while tryptophan appears to enhance the serotonergic system exclusively, 5-hydroxytryptophan also appears to enhance the catecholaminergic system.41 4. Reactive Hypoglycemia There is early evidence that hypoglycemia during glucose tolerance testing is related to hostile, aggressive behavior such as that seen in habitually violent and impulsive criminals.34 Virkkunin, for example, found that a group of habitually violent adult criminals had lower basal glucose levels during glucose tolerance testing than controls.42 Even in the normal population, there is evidence of a relationship between hypoglycemic tendencies and both frustration and hostility.43 Assuming that there is an association between hypoglycemia and the aggressive behavioral syndrome, the question of whether hypoglycemia causes the syndrome remains. One method of investigating the issue of causality is by changing the amount of sugar in the diet and examining the behavioral effects. Since dietary sugar provokes insulin production which may cause a reactive hypoglycemia, a change in behavior following a change in sugar intake would be consistent with the hypothesis that dietary sugar influences that behavior. In a series of increasingly sophisticated double-blind studies, Schoenthaler addressed this question by reducing the sugar intake of thousands of incarcerated juvenile offenders in different locations around the United States. Compared to offenders on a placebo diet, he found a significant reduction in various forms of antisocial behavior (such as assaultiveness, fighting, self-injury and suicide attempts) in offenders restricted to a minimal amount of sugar in their diet - but only for the males.44 While Schoenthaler's work suggests that dietary sugar may influence behavior, he did not examine blood sugar levels; it thus fails to address the role of reactive hypoglycemia in the aggressive behavioral syndrome. The finding that only males responded may either be because males are more likely to engage in aggressive behaviors, or because males are more sensitive to nutritional influences on aggression. (Remember that the lack of tryptophan in the diet only increased aggression during spontaneous play in the male monkeys.) Further studies are needed to address these important questions. 5. Food Sensitivities It appears that overaggressive behaviors can be provoked by a reaction to common foods. Reactions range from irritability to a psychotic aggressive reaction. Children who improved after food eliminations had previously been irritable, fretful, quarrelsome and could not get along with others. Often they had to be taken out of school as they upset the classes and were considered incorrigible. After food eliminations, however, their personalities dramatically changed, and they became happy and social.45 A study reported in the Lancet suggests that food sensitivities may be quite common among behaviorally- disturbed children. Eighty-one out of a group of 140 children with behavior disorders (almost two-thirds) experienced significant improvement following the elimination of certain foods along with food additives. When they were challenged with the specific foods which had been eliminated, their behavior problems returned. Moreover, 75% of these children reacted to a double-blind challenge with salicylates but not to placebo.46 The following case study, reported in Psychology Today, illustrates how food sensitivities may affect aggressive behavior: When he was five years and one month old, G.L. was seen because of uncontrollable temper tantrums. He was believed aphasic because of poor speech development, and was too uncomfortable to do initial IQ testing. The EEG showed 14-per-second spikes, large amounts of sharp activity in the motor leads, temporal single, polyphasic sharp waves, and a long run of sharp waves in the right temporal area. Allergy tests revealed strong reactions to milk, chocolate and yeast. He was placed on a diet free of milk, chocolate, and cola drinks. Seven and one half months later, his EEG was normal. Six months after the repeat EEG, he was learning better and his behavior was much improved. He was challenged again with the suspected foods for one week, during which time his behavior again became uncontrollable. The EEG now showed two-and-one-half to six-per-second activity on the right, greater in the mid-temporal and parietal leads, accentuated by drowsiness. Light cerebral dysfunction was diagnosed.47 Adults may also display overaggressive behaviors due to food sensitivities. For example, MacKarness has written of a woman who had been hospitalized thirteen times for violent behavior and depression; after common foods were eliminated from her diet, she no longer became violent or depressed. Instead she felt fine and obtained a regular job.48 While the research literature suggests that any commonly ingested food or food additive may be responsible for provoking pathological psychological and behavioral reactions, milk may be a special case. Schauss and Simonsen found that chronic juvenile delinquents consumed much more milk than matched controls without a history of delinquency. The male offenders consumed an average of a gallon of milk daily compared to a little less than a quart a day for the controls, and the females showed similar differences.49 Schauss believes that overconsumption of milk causes antisocial behavior. He has reported that, when several Michigan detention centers reduced their inmates' milk consumption, the incidence of antisocial behavior declined; when they permitted milk consumption to increase again, antisocial behavior also increased.50 Discussion and Summary The literature offers numerous clues, but little scientific verification, consistent with the hypothesis that the aggressive behavioral syndrome can be prevented and treated by manipulating nutritional factors. Epidemiological studies have repeatedly found associations between overaggressive behaviors and deficiencies of several essential nutrients: niacin, pantothenic acid, thiamine, vitamin B6, vitamin C, iron, magnesium and tryptophan. While repletion of frank deficiencies is likely to be beneficial, the benefit of correcting marginal deficiencies remains to be proven. Not an essential nutrient, lithium has been proven effective in reducing overaggressive behaviors when provided at massive pharmacologic dosages. Moreover, even the relatively tiny daily lithium intake from municipal water supplies has been found to be negatively correlated with measures of the aggressive behavioral syndrome. In an open trial, supplementation with such natural levels of lithium appeared to be effective in treating bipolar depression. These findings suggest that natural lithium supplementation may be effective in the management of the aggressive behavioral syndrome, a hypothesis which remains to be explored experimentally. There is some evidence that overaggressive behaviors may be promoted by the toxic effects of aluminum, cadmium and lead. Exposures to these elements (especially cadmium and lead) should be avoided; it is unknown whether treatments designed to chelate these metals in order to remove them from the brain are effective in reducing overaggressive behaviors. Reactive hypoglycemia may be more common among people displaying the aggressive behavioral syndrome and, in an open study, reducing sugar consumption was followed by a reduction in antisocial behavior. Whether treating documented reactive hypoglycemia reduces overaggressive behaviors remains unknown. Finally, sensitivities to foods and food additives appear capable of inducing overaggressive behaviors. Most of the evidence remains anecdotal; however, salicylates have been shown to provoke behavioral disturbances under double-blind conditions. Despite the relative paucity of scientific evidence from controlled studies, clues from case reports, open trials, observational (correlational) studies and animal studies suggest that attention to nutritional factors may reduce overaggressive behaviors and the devastation resulting from them. Those clues, plus the safety of most nutritional interventions, argue that a nutritional approach should be considered in the treatment of the aggressive behavioral syndrome. References 1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, D.C., American Psychiatric Association, 1987. 2. Hanes: Health and Nutrition Examination Survey. U.S. Dept. of HEW Publication No. (HRA) 74-1219-1, Rockville, MD, 1974. 3. Tucker DM et al: Nutrition status and brain function in aging. Am. J. Clin. Nutr. 52:93-102, 1990. 4. Gelenberg AJ: Psychiatric Disorders, in DM Paige, Ed. Clinical Nutrition, Second Edition. St. Louis, The C.V. Mosby Company, 1988. 5. Hodges RE et al: J. Clin. Invest. 38:1421, 1959. 6. Lonsdale D, Shamberger R: Red cell transketo-lase as an indicator of nutritional deficiency. Am. J. Clin. Nutr. 33(2):205-11, 1980. 7. McLaren DS: Clinical manifestations of nutritional disorders, in ME Shils & VR Young. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 8. Wilmot CA et al: Ascorbic acid inhibits isolation-induced fighting in mice. Fed. Proc. 42:1160, 1983. 9. Brin M: Examples of behavioral changes in marginal vitamin deficiency in the rat and man, in J. Brozek, Ed. Behavioral Effects of Energy and Protein Deficits. United States Department of Health, Education and Welfare Publ. no. (National Institute of Health) 79-1906, 1979. 10. Baily L, Gensburg J, Wagner P et al: Serum ferritin as a measure of iron stores in adolescents. J. Pediatr. 101:774-6, 1982. 11. Youdim MB et al: Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am. J. Clin. Nutr. 50(3 Suppl.):607-15, 1990. 12. Webb TE, Oski FA: Behavioral status of young adolescents with iron deficiency anemia. J. Special Ed. 8(2):153-6, 1974. 13. Rosen GM, Deinard AS, Schwartz S et al: Iron deficiency among incarcerated juvenile delinquents. J. Adolesc. Health Care 6:419-23, 1985. 14. Wickham EA, Reed JV: Lithium for the control of aggressive and self-mutilating behavior. Int. Clin. Psychopharmacol. 2(3):181-90, 1987. 15. Campbell M et al: Behavioral efficacy of halo-peridol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch. Gen. Psychiatry 41(7):650-6, 1984. 16. Glenn MB et al: Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am. J. Phys. Med. Rehabil. 68(5):221-6, 1989. 17. Spreat S et al: Lithium carbonate for aggression in mentally retarded persons. Comp. Psychiatry 30(6):505-11, 1989. 18. Schrauzer GN, Shrestha KP: Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biol. Trace Elem. Res. 25(2):105-13, 1990. 19. Fierro AA: Natural low dose lithium supplementation in manic-depressive disease. Nutr. Perspectives January, 1988:10-11. 20. Kantak KM: Magnesium deficiency alters aggressive behavior and catecholamine function. Behav. Neurosci. 102(2):304- 11, 1988. 21. Izenwasser SE et al: Stimulant-like effects of magnesium on aggression in mice. Pharmacol. Biochem. Behav. 25(6):1195-9, 1986. 22. Henrotte JG: Type A behavior and magnesium metabolism. Magnesium 5:201-10, 1986. 23. Banki CM et al: Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol. Psychiatry 20(2):163-71, 1985. 24. Gottschalk LA et al: Abnormalities in hair trace-elements as indicators of aberrant behavior. Compr. Psychiatry 32:229-37, 1991. 25. Barlow PJ: A pilot study on the metal levels in the hair of hyperactive children. Med. Hypotheses 11(3):309-18, 1983. 26. Collipp PJ: Manganese in infant formulas and learning disability. Ann. Nutr. Metab. 27:488-94, 1983. 27. Mannuzza S et al:P Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch. Gen. Psychiatry 48:77- 83, 1991. 28. Chandra SV: Psychiatric illness due to manganese poisoning. Acta Psychiatr. Scand. Suppl. 303:49-54, 1983. 29. Thomson GO et al: Blood-lead levels and children's behaviour: results from the Edinburgh Lead Study. J. Child Psychol. Psychiatry 30(4):515-28, 1989. 30. Pihl RO et al: Hair element content of violent criminals. Can. J. Psychiatry 27:533, 1982. 31. Struempler RE et al: Hair mineral analysis and disruptive behavior in clinically normal young men. J. Learn. Disabil. 18(10):609-12, 1985. 32. Schmidt K et al: Clinical ecology treatment approach for juvenile offenders. J. Behav. Ecology: Biosocial 2(1), 1981. 33. Rees EL: Aluminum toxicity as indicated by hair analysis. J. Orthomol. Psychiatry 8:37, 1979. 34. Roy A et al: Monamines, glucose metabolism, aggression towards self and others. Int. J. Neurosci. 41(3-4):261-4, 1988. 35. Giammanco S et al: Short term diet of precooked corn meal almost lacking in tryptophan and interspecific rat-mouse aggressive behavior. Arch. Int. Physiol. Biochim. 98(1):23-6, 1990. 36. Kitahara M: Dietary trypotophan ratio and homicide in Western and Southern Europe. J. Orthomol. Med. 1(1):13-6, 1986. 37. Branchey L et al: Depression, suicide and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res. 12(3):219-26, 1984. 38. Chamberlain B et al: The effect of raising or lowering tryptophan levels on aggression in vervet monkeys. Pharmacol. Biochem. Behav. 28(4):503-10, 1987. 39. Morand C et al: Clinical response of aggressive schizophrenics to oral tryptophan. Biol. Psychiatry 18(5):575-8, 1983. 40. Volavka J et al: Tryptophan treatment of aggressive psychiatric patients. Biol. Psychiatry 28(8):728-32, 1990. 41. Raleigh MJ: Differential behavioral effects of tryptophan and 5-hydroxytryptophan on vervet monkeys: influence of catecholaminergic systems. Psychopharmacology (Berlin) 93(1):44-50, 1987. 42. Virkkunen M: Reactive hypoglycemia tendency among habitually violent offenders: A further study by means of the oral glucose tolerance 43. Benton D et al: Mild hypoglycaemia and questionnaire measures of aggression. Biol. Psychol. 14(1-2):129-35, 1982. 44. Schoenthaler SJ: Int. J. Biosocial Res. Vol. 3-5, 1982-3. 45. Clarke TW: The relation of allergy to character problems in children: A survey. Ann. Allergy March-April, 1950, pp. 175- 87. 46. Swain A et al: Salicylates, oliogoantigenic diets, and behaviour. Letter. Lancet 2:41-2, 1985. 47. Moyer KE: Allergy & aggression: The physiology of violence. Psychol. Today July, 1975, pp. 77-9. 48. MacKarness R: Eating Dangerously. New York, Harcourt, Brace, Jovanovich, 1976. 49. Schauss AG, Simonsen CE: Critical analysis of the diets of chronic juvenile offenders: Part I. J. Orthomol. Psychiatry 8(3):149-57, 1979. 50. Schauss AG: Nutrition and antisocial behaviour. Int. Clin. Nutr. Rev. 4(4):172-7, 1984.

Labels: , , , , , , , , , , , , , ,

Thursday, August 30, 2007

Supplements for ADHD

ADD & ADHD ADD & ADHD Natural Control of ADD & ADHD Billie J. Sahley, Ph.D., CNC In Toxic Psychiatry, Peter Breggin, MD states, Hyperactivity is the most frequent justification for drugging children. Difficult-to-control children are certainly not a new phenomenon, but attempts to give them a medical diagnosis are the product of modern psychology and psychiatry. At first, psychiatrists called hyperactivity a brain disease: minimal brain dysfunction (MBD). When no minimal brain dysfunction could be demonstrated, the label became attention deficit disorder (ADD). Six million children in this country suffer some type of learning disability, ADD, or ADD with hyperactivity (ADHD). Over two million children currently take Ritalin for ADD/ADHD. ADD and ADHD may be caused by psychological problems, including trauma and abuse, nutritional deficiencies, chemical imbalances, allergic responses to food and chemicals, or a poor diet. A failure in the brains inhibitory system (the ability of the brain to inhibit and control itself) may also cause ADD/ADHD. Ritalin, the most commonly used drug for ADD and ADHD, is an amphetamine and a Schedule II class drug (other Schedule II drugs are morphine, opium, and medicinal cocaine). Doctors prescribe Ritalin for many children who do not need it, causing a number of adverse mental and physical side effects. Yet this potent, toxic drug is being used as a quick fix to quiet children. Surprisingly, prescription rates for Ritalin doubled between 1992 and 1996. Children demonstrating symptoms of anxiety, ADHD or ADD often have an imbalance in their brains biochemistry. A biochemical imbalance results from a deficiency of neurotransmitters, the chemical messengers of the brain. If a biochemical imbalance goes untreated, a child can display maladaptive behavior, followed by possible long-term physical and emotional problems. A childs state of health reflects his or her state of nutrition. When minerals, vitamins, amino acids, enzymes, or even hormones are deficient in a childs system, the result can be a disturbed biochemical homeostasis causing impaired functions in the brain. This, in turn, can cause an inability to focus, concentrate, and stay on task. At the Pain and Stress Center in San Antonio, we have successfully treated numerous children with orthomolecular therapy. Orthomolecular therapy corrects the brains biochemical imbalance, without toxic drugs that can produce adverse side effects. ADD/ADHD presents a major problem facing parents today. Most people think of hyperactivity as some type of behavioral problem (a child who is impatient, impulsive, and constantly moving); but not all hyperactive children are aggressive. Some are very passive, withdrawn, and find it hard to communicate their feelings. ADD/ADHD is not a condition that can be measured in precise scientific terms. Nor is it a situation with a quick fix, especially with powerful and addictive drugs such as Ritalin. ADD/ADHD is a complex and intricate condition in which children demonstrate maladaptive or disorganized behaviors, which put them out of sync with the world around them. Numerous clinical studies established that hyperactive children often have low serotonin levels. A proper combination of tryptophan or 5-HTP and B6, elevates the serotonin level and balances the brain; the childs symptoms diminish. The dosage, of course, depends on the childs age, weight, and the degree of hyperactivity. Effectiveness of Amino Acids Neurotransmitters affect behavior and learning. A neurotransmitter deficiency consequently has a dramatic effect on childrens or adults abilities to learn and function in an orderly manner. Most hyperactive and ADD children are born with a shortage of neurotransmitters, establishing a genetic link, most often on the male side. These children also do not manufacture the needed amount of these chemical messengers. Where do we get neurotransmitters? From the amino acids, GABA, glycine, taurine, tyrosine, glutamine and tryptophan. Do children or adults get enough aminos through diet? NO! Balanced amino-acid doses, in the right combination and formulas, produce the needed neurotransmitters naturally. Using a stimulant medication to try to produce neurotransmitters is like a shotgun going off in the childs brain. Our children were not born with Ritalin in their brain, so how can they have a Ritalin deficiency? Approximately fifty different neurotransmitters exist in the human brain, but communication between brain cells uses only ten (approximately) major neurotransmitters. How we feed the brain directly affects our production of neurotransmitters. With proper nutrition and supplementation, we can correct or enhance mind, mood, memory, and behavior. All major neurotransmitters are made from amino acids and dietary protein. One of the dangers of a low-protein diet is not ingesting enough amino acids to make adequate brain neurotransmitters. Apathy, lethargy, difficulty concentrating, loss of interest, and insomnia all result when the diet does not include adequate amounts of amino acids. Drugs do not produce or increase production of neurotransmitters. Drugs only address symptoms. Amino acids restore the balance nature intended. Some of the major symptoms of neurotransmitter deficiencies are ADD, ADHD, brain fog, mood swings, increased stress, anxiety, depression, insomnia, irritability, and aggression. Stress plays a major role in the depletion of neurotransmitters. Inhibitory neurotransmitters are the keys to behavior, emotions, and pain. Inhibitory amino acids include tryptophan, taurine, GABA, and glycine. Millions of people have turned to drugs known as SSRIs (Selective Serotonin Reuptake Inhibitors). These drugs, such as Prozac, Paxil, Zoloft, and Effexor work by selective enhancement of serotonin levels. SSRIs prevent the presynaptic nerve from reabsorbing serotonin that it previously secreted. Prozac causes an increase in brain serotonin levels; but Prozac and other prescription drugs do not increase neurotransmitters. (See Figure 1). 5-HTP is synergistic with other supplements that enhance neurotransmitters such as GABA, glutamine, tyrosine, phenylalanine, and glycine. Magnesium prolongs the benefits of 5-HTP. Chronic stress depletes available serotonin, as well as interferes with serotonins ability to control behavior. Research demonstrates that low serotonin levels can change brain function and impair learning. Low serotonin may be responsible for an increase in depression and drug use among teens and children. Most teens with low serotonin levels are more prone to try recreational drugs or even prescription drugs, for relief. A low brain serotonin level impairs the ability to focus and reason. 5-HTP shows a lot of promise as a natural answer to a multitude of problems that plague adults and children. Use caution with 5-HTP if your child is taking prescription antidepressant medications. GABA (Gamma-aminobutyric acid) GABA, an inhibitory neurotransmitter, is found throughout the central nervous system. GABA assumes an ever-enlarging role as a significant influence on ADD, ADHD, stress, anxiety, and depression, as well as stress-induced illnesses. According to Candace Pert, a neuroscientist who discovered the GABA receptor, every cell in the body has a GABA receptor, which is one reason why GABA has such positive effects. GABA inhibits the cells from firing, diminishing anxiety-related messages. Tranquilizers provide only temporary relief. We have seen many patients on Xanax that still experience anxiety. They have been told it is not addictive: it is! THERE IS NO SUCH THING AS A TRANQUILIZER DEFICIENCY! Nutrient deficiencies do occur, however; and they can and do change behavior. GABA, glutamine, and glycine prove vital for energy and the smooth running of brain functions. We have successfully used these three amino acids with patients to ease anxiety, irritability, and ADD. Research demonstrates a large number of children who display ADD/ADHD behavior actually experience anxiety. If they use all available GABA, then the receptors in the brain become empty, allowing the brain to be bombarded with random firings of excitatory messages. However, when adequate amounts of GABA are present, the reception of multiple random firings are blocked, so the brain does not become overwhelmed. At the Pain & Stress Center we regularly combine GABA and other amino acids to achieve positive results. Dose amounts vary, depending on the age and weight of the child. GABA now takes its place as a major influence on those taking drugs, and in many cases, replacing the drugs. We have found that, when combined with other amino acids, GABA works exceptionally well with ADD children. L-Glutamine Glutamine, along with GABA and Glycine, is rapidly becoming an important therapeutic amino acid of the 21st century. Glutamine, found in many foods, is the third most abundant amino acid in the blood and brain. It also provides a major alternative fuel source for the brain when blood sugar levels are low. Glutamine functions as an inhibitory neurotransmitter, and is the precursor for GABA, the antianxiety amino acid. The amino acid trio of Glutamine, GABA, and Glycine plus B6 are among the major inhibitory neurotransmitters in the brain. Glutamine is found in the nerves of the hippocampus, the memory center of the brain, in the cranial nerves, and in many other areas of the brain. These three amino acids work together as inhibitory neurotransmitters. Anyone taking amino acids must take B6 to metabolize the amino acids. Intellectually impaired children and adults often show an increase in IQ after taking glutamine in combination with Ginkgo biloba and B6. Dr. Roger Williams demonstrated that children and adults diagnosed with ADHD showed a marked improvement when taking 250 mg to 1,000 mg of glutamine daily. GABA and glutamine are not only found in the brain, but also in the receptor sites throughout the body. Glutamine is the memory and concentration amino acid. Seventy five percent of hyperactive and ADD childrens blood tests showed low levels of glutamine. Dr. C. Fredericks research also demonstrated a definite increase in the IQs of children given glutamine. When glutamine was given daily, children showed impressive improvements in their abilities to learn, to retain, and to recall. Glutamine is a major part of my orthomolecular program for hyperactive and ADHD children. Glutamine is one of the amino acids that create the neurotransmitters in the brain that enhance learning and memory. Hyperactive and ADD children have low neurotransmitter levels, especially glutamine. Adding glutamine increases the level of neurotransmitters. Start with 500 mg of glutamine and gradually increase until you reach the optimal dose for your child, to a maximum of 3,000 mg per day. Taurine Taurine is now classified as a conditionally essential amino acid in the adult. In infants and children, however, taurine is an essential amino acid. As one of the sulfur amino acids, adults synthesize taurine from cysteine and methionine, provided B6 and zinc are present. Taurine is found abundantly throughout the body in the heart, olfactory bulb, central nervous system, and brain (hippocampus and pineal gland). As an inhibitory neurotransmitter, taurine, after GABA, is the second-most important inhibitory transmitter in the brain. Taurines inhibitory action in the brain equals that of GABA and glycine. Its inhibitory effect is one source of taurines anticonvulsant and antianxiety properties. Some children with Downs syndrome have shown an increase in IQ levels when taurine was added to their diet along with glutamine, B6, and vitamin E. The need for taurine increases whenever you experience more stress than usual, or have an illness. Tyrosine Tyrosine is the amino acid and inhibitory neurotransmitter that often helps overcome depression. Clinical studies show that tyrosine controls medication-resistant depression. In a 1980 issue of the American Journal of Psychiatry, a study by Dr. Alan Gelenberg of Harvard Medical School discussed the role of tyrosine in the control of anxiety and depression. Dr. Gelenberg postulated that the lack of available tyrosine results in deficiency of the hormone norepinephrine at a specific location in the brain that relates to mood problems such as depression. Children given tyrosine supplementation demonstrated a marked improvement in mental performance and mood stability. Tyrosine, because of its role in assisting the body to cope physiologically with stress and building the bodys natural store of adrenaline, deserves to be called the stress amino acid. Stress exhaustion requires tyrosine. During periods of stress, in order to continue coping with stress physiologically, the brain requires tyrosine. Tyrosine aids children and young teens, as well as adults, with recurrent depression and mood disorders. In children, dosage ranges from 200 to 500 mg daily. Glycine Glycine is a nonessential amino acid, with the simplest structure of all the amino acids resembling glucose (blood sugar) and glycogen (excess sugar converted in the liver for storage). Glycine is sweet to the taste, can be used as a sweetener, and can mask bitterness and saltiness. Pure glycine dissolves readily in water. As the third major inhibitory neurotransmitter in the brain, glycine readily passes the blood-brain barrier. Studies by the late Carl Pfeiffer, MD, Ph.D., demonstrated glycine as an important factor in psychiatric disorders. Glycine decreases the craving for sugar, and, in many cases, can replace sugar on foods such as cereal. Glycine calms aggression in both children and adults. When combined with GABA and glutamine, glycine influences brain function by slowing down anxiety-related messages from the limbic system. As a very nontoxic amino acid, both children and adults can use glycine. Glycine can be mixed with other amino acids. Doses for a child range between 500 to 2,000 mg daily, divided. Magnesium Hyperactive or ADD children are almost always deficient in magnesium. Magnesium proves necessary for proper brain energy and is the first mineral depleted when anyone (child or adult) is under stress. Magnesium is a stress mineral, and deficiency can lead to hyperactive or ADD behavior. Magnesium plays a significant role in sugar metabolism and in the proper utilization of carbohydrates to create energy. Magnesium is so very important in a childs diet, especially if he displays hyperactive behavior, ADD, or other behavioral problems. Magnesium can be taken in liquid form, tablet, or capsule. When added to the ADD/ADHD diet, calming effects sometimes occur immediately. Most magnesium exists inside the cells where it activates enzymes necessary for the metabolism of carbohydrates and amino acids. In 1988, a study published in Alternative Medicine Review linked the development of ADHD to low blood-serum magnesium levels. A group of children followed for six months were given 200 mg of magnesium a day. Researchers noted remarkably decreased hyperactivity in the children. As a major nutrient needed by ADD/ADHD children and adults, magnesium is the number one stress mineral needed by the body. Magnesium is responsible for over three hundred enzyme functions. It cannot be stored by the body, and it must be taken daily. Symptoms of magnesium deficiency include asthma, migraines, eye twitches, anxiety, confusion, muscle spasms, irritability, depression, nervousness, fatigue, mood swings, PMS, hypertension, and insomnia. Calcium A calcium deficiency can also induce ADD/ADHD behavior. A child deficient in calcium exhibits irritability, sleep disturbances, anger, and inattentiveness. The first signs of a calcium deficiency include nervous stomach, cramps, tingling in the arms and legs, and painful joints. A calcium deficiency can also lead to ADD/ADHD behavior. Children sensitive to dairy products must receive daily calcium supplementation in capsule, chewable, or liquid form. Children up to 10 years of age need 1000 mg of calcium daily; adolescents need 1,200 to 1,500 mg daily. For those involved in sports activities, calcium supplementation is a must. Huperzine Recent research reports that Huperzine A improves mental function and learning in adolescents. Chinese researchers designed a study to determine the efficiency of Huperzine on memory and learning. The clinical study included 34 matched pairs of junior middle school students that had significant complaints of poor memory and difficulty in learning. In the double blind trial, half of the students received a placebo while the other half received Huperzine A for four weeks. Academic performance was measured before and after the clinical trial. The Huperzine group scored significantly better on standard memory tests without side effects. Huperzine A is an extract derived from Chinese club moss. Huperzine can be combined with amino acids and other nutrients. The suggested dosage is one 50 mcg capsule in the morning and in the evening for children aged 12 and over. This information is excerpted from my book Control Hyperactivity/ADD Naturally. Other resources include Is Ritalin Necessary? Both are available through: Pain & Stress Center 5282 Medical Dr. #160 San Antonio, TX 78229-6023

Labels: , , , , , , , , , , , ,